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Abstract: Maitotoxins (MTXs) are among the most potent toxins known. These toxins are produced
by epi-benthic dinoflagellates of the genera Gambierdiscus and Fukuyoa and may play a role in causing
the symptoms associated with Ciguatera Fish Poisoning. A recent survey revealed that, of the
species tested, the newly described species from the Canary Islands, G. excentricus, is one of the most
maitotoxic. The goal of the present study was to characterize MTX-related compounds produced
by this species. Initially, lysates of cells from two Canary Island G. excentricus strains VGO791
and VGO792 were partially purified by (i) liquid-liquid partitioning between dichloromethane and
aqueous methanol followed by (ii) size-exclusion chromatography. Fractions from chromatographic
separation were screened for MTX toxicity using both the neuroblastoma neuro-2a (N2a) cytotoxicity
and Ca2+ flux functional assays. Fractions containing MTX activity were analyzed using liquid
chromatography coupled to high-resolution mass spectrometry (LC-HRMS) to pinpoint potential
MTX analogs. Subsequent non-targeted HRMS analysis permitted the identification of a novel MTX
analog, maitotoxin-4 (MTX4, accurate mono-isotopic mass of 3292.4860 Da, as free acid form) in the
most toxic fractions. HRMS/MS spectra of MTX4 as well as of MTX are presented. In addition, crude
methanolic extracts of five other strains of G. excentricus and 37 other strains representing one Fukuyoa
species and ten species, one ribotype and one undetermined strain/species of Gambierdiscus were
screened for the presence of MTXs using low resolution tandem mass spectrometry (LRMS/MS). This
targeted analysis indicated the original maitotoxin (MTX) was only present in one strain (G. australes
S080911_1). Putative maitotoxin-2 (p-MTX2) and maitotoxin-3 (p-MTX3) were identified in several
other species, but confirmation was not possible because of the lack of reference material. Maitotoxin-4
was detected in all seven strains of G. excentricus examined, independently of their origin (Brazil,
Canary Islands and Caribbean), and not detected in any other species. MTX4 may therefore serve as
a biomarker for the highly toxic G. excentricus in the Atlantic area.
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1. Introduction
Maitotoxin (MTX) (Figure 1) is among the most potent marine toxins identified to date, with
an intraperitoneal (i.p.) lethal dose 50 (LD50) in mice of 0.050 µg kg−1 [1]. Its oral potency, however,
is much lower [2], probably due to low intestinal absorption caused by its high molecular weight and
hydrophilicity. Consequently, MTX is primarily found in the tissues associated with the digestive
tract of fish and is believed to play a role in ciguatera fish poisoning (CFP) if gut and liver tissues are
consumed [3].
Maitotoxin was first detected in 1976 in the viscera of the bristletooth surgeonfish
Ctenochaetus striatus (in Tahitian “maito”, hence its name) collected in Tahiti (French Polynesia) and
it was initially suspected of contributing to the diversity of ciguatera symptoms [4,5]. Eleven years
later, the toxin was isolated from the dinoflagellate Gambierdiscus by Yasumoto, et al. [6] confirming the
source of the toxin isolated from contaminated fish. Purified MTX exists as a white amorphous solid
that is soluble in polar solvents (e.g., water, methanol and dimethylsulfoxide) and it is relatively stable
in alkaline but not in acidic conditions. In aqueous solution, pure MTX tends to adhere to both glass
and plastic surfaces [7,8]. When dissolved in methanol-water, MTX exhibits a single UV absorbance
maximum at 230 nm [9] due to the presence of a conjugated diene at one extremity of the molecule
(C2-C3-C4-C144, Figure 1).
Experiments using purified MTX showed it causes a rapid influx of external Ca2+ and a steep
increase of intracellular Ca2+ (iCa2+) concentration in a wide variety of cells [10,11]. The Ca2+
influx elicited by MTX leads to numerous secondary events, including: depolarization in neuronal
cells [12], phosphoinositide breakdown [13], smooth muscle contraction [14–16], induction of acrosome
reaction in sperm [17–19], secretion of neurotransmitters (e.g., dopamine [20], noradrenaline [21,22],
GABA [23]), hormones (e.g., insulin [24,25]) and inflammatory intermediates (e.g., arachidonic acid [26]
and histamine [27]), formation or activation of large cytolytic/oncotic pores [28–30].
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Figure 1. Absolute stereochemistry of maitotoxin (MTX) according to Sasaki et al. [31] and
Nonomura et al. [32].
The complete chemical structure of MTX was elucidated in 1993 following purification from the
Gambierdiscus strain (GII-1) isolated from Gambier Islands (French Polynesia) [1]. That analysis showed
MTX is the largest non-polymeric marine toxin identified to date, consisting of a ladder-shaped cyclic
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polyether that is composed of 32 fused ether rings, 28 hydroxyl groups, 21 methyl groups, two sulfates
and 98 chiral centers (molecular formula: C164H256O68S2Na2, mono-isotopic mass = 3423.5811 Da
for the di-sodium salt). In 1996, the stereochemistry of the entire molecule was also assigned [31–33]
(Figure 1). Gallimore and Spencer [34] contested the stereochemistry of the junction between J and K
rings according to a mechanistic hypothesis for the biosynthesis of marine ladder-shaped polyethers.
Subsequent studies by Nicolaou and Frederick [35] and Nicolaou, et al. [36] supported the originally
assigned structure based on NMR spectroscopic data, computational studies and providing chemical
synthesis and NMR analysis of the GHIJK ring system. X-ray crystal structure of MTX is needed to
solve this controversy.
Though the effects of MTX at the cellular level are well characterized, its actual mode of action
has not been fully elucidated. Initially, MTX was considered to be a specific activator of voltage-gated
calcium channels [37–39]. In actuality, MTX increases iCa2+ by activating a voltage-independent Ca2+
entry mechanism in the plasma membrane, without directly promoting the release of Ca2+ from
intracellular storage compartments [40–42]. So far, MTX has been shown to activate non-selective
ion channels, probably involving TRPC1 (transient receptor potential canonical 1) [40,41,43,44].
The activation of the sodium-calcium exchanger in reverse mode has also been observed in rat
aortic smooth muscle cells [45]. The activation of the sodium-hydrogen exchanger equally appears
to play a role in MTX cytotoxic activity in cortical neurons [46] and it may be a consequence of
MTX-induced intracellular acidification, probably involving voltage-gated sodium channels [47].
Maitotoxin is also likely to convert the Ca2+-ATPase (PCMA) pump into a Ca2+-permeable non-selective
ion channel, as demonstrated in PCMA-overexpressed Spodoptera frugiperda (Sf9) insect cells and
human embryonic kidneys (HEK-293 cells) [48]. To date, it is unclear whether MTX directly interacts
with any of these targets. Several research groups have postulated that MTX may bind a still
undescribed MTX-receptor [35,42,49,50]. Since the specific molecular target of MTX is still unknown, its
structure-activity relationship can only be inferred based on its NMR structural features and analogies
with other ladder-shaped polyether toxins. Konoki, et al. [51] first hypothesized that the hydrophobic
side of MTX (rings R through F’) penetrates the phospholipid bilayer of cell membranes and the
hydrophilic portion of the molecule, presenting the polyhydroxy- groups and the two sulfate ester
groups (rings A through Q), remains outside the cell (Figure 1). Modeling studies conducted by
Reyes et al. [11] corroborate this hypothesis.
Sulfate ester groups seem to be critical for the biological activity of MTXs [52,53]. A study
conducted by Murata et al. [52] in particular showed that desulfatation or hydrogenation of MTX
significantly decreased its ability to induce Ca2+ influx or phosphoinositide breakdown in insulinoma
or glioma cells. Murata, et al. [54] also hypothesized that a self-assemblage of four or more molecules
could occur to form a pore on cell membranes for non-selective ion influx; however, this hypothesis
has not been confirmed.
During the 1990s, two other MTX analogs, MTX2 and MTX3, were isolated by Holmes et al. [53,55].
Maitotoxin-2 (MTX2) was obtained from a single Australian Gambierdiscus strain from Queensland
(NQ1) [55]. It had an i.p. LD50 in mice of 0.080 µg kg−1 [53], i.e., 1.6-fold less toxic than MTX [1]. When
dissolved in acetonitrile-water, MTX2 had a single UV absorbance maximum at 230 nm [53], identical to
that reported for MTX in methanol-water [9]. The molecular structure of MTX2 has not been elucidated
yet. Lewis, et al. [56] conducted LC-LRMS analyses of material isolated from strain NQ1 in ionspray
ionization in positive ion acquisition mode (IS+), ionspray ionization in negative ion acquisition mode
(IS−) and fast atom bombardment ionization in negative ion acquisition mode (FAB−) and suggested
that MTX2 is mono-sulfated with a molecular weight (MW) of 3298 Da (as mono-sodium salt).
Maitotoxin-3 (MTX3) was isolated from the Australian Gambierdiscus strain WC1/1 [53].
Maitotoxin-3 was found to be toxic in mice, inducing similar symptoms than those observed for
MTX and MTX2, but scarcity of the purified compound did not permit the determination of MTX3
potency (i.p. LD50 in mice) [53]. On a reversed-phase column, MTX3 elutes earlier than MTX2 and later
than MTX when using a linear gradient of acetonitrile/water [53]. When dissolved in acetonitrile-water,
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MTX3 had a UV spectrum composed of two peaks, a minor peak at 200 nm and a major peak at 235 nm,
slightly higher than MTX and MTX2 [53]. Lewis et al. [56] conducted LC-LRMS analyses of material
isolated from strain WC1/1 in IS+ acquisition mode. Their results suggested that MTX3 is di-sulfated
with a MW = 1060.5 Da (as di-sodium salt). The actual molecular structure of MTX3 has yet to
be determined.
Since the molecular structures of MTX2 and MTX3 are still unknown, the only structural feature
that is known to be common to the MTX class of toxins is the presence of (at least) one sulfate ester
group. Desulfatation experiments conducted by Holmes and Lewis [53] on the three MTX analogs
again suggested that at least one of the sulfate ester groups is critical for the bioactivity.
A schematic summary of the properties of three MTXs known to date with relevant chemical
information is listed in Table 1. A recent study conducted by Lewis et al. [57] indicated that several
strains of Gambierdiscus/Fukuyoa produce multiple MTX congeners, in one case more than four
(G. belizeanus CCMP399), suggesting broader chemical diversity than what is known so far within MTX
group. These analogs are not listed here since no further information beyond activity was provided in
that study.
Table 1. List of the three MTXs known to date with relevant chemical information. Gambierdiscus sp.
GII-1 was isolated from Gambier Islands (French Polynesia); Gambierdiscus sp. NQ1 from Queensland
(Australia) and Gambierdiscus sp. WC1/1 from Australia. FAB−: fast atom bombardment ionization in
negative ion acquisition mode. IS+: ionspray ionization in positive ion acquisition mode. IS−: ionspray
ionization in negative ion acquisition mode. UNKN: unknown.
Name Abbr. Formula Mass (Da) Structural Studies Toxicity (i.p. LD50in Mice, µg kg−1) Source Reference
Maitotoxin MTX C164H256O68S2Na2 3423.5811








salt of a molecule
containing one
sulfate ester)
3298 UV (λmax = 230 nm)LRMS: IS+, IS−, FAB− 0.080 NQ1 [55]
Maitotoxin-3 MTX3
UNKN (di-sodiated
salt of a molecule
containing two
sulfate esters)
1060.5 UV (λmax = 200,235 nm) LRMS: IS+ UNKN WC1/1 [53]
Fifteen Gambierdiscus and three Fukuyoa species have been described in the past few
decades [58–66]. As previously suggested [58], ongoing taxonomic studies being conducted by
Tunin-Ley, et al. [67] also indicate that the biological diversity within these genera could be much
higher than expected to date. The functional MTX toxicity for many of these species has been examined
using erythrocyte lysis assay [68,69] or neuroblastoma SH-SY5Y Ca2+ assay [57]. Of the species tested,
G. excentricus, which was described from isolates obtained in the Canary Islands, exhibited much
higher maito- and cigua (CTX)-toxicity than any other species known to occur in the Atlantic [61,69].
Its MTX- and CTX-toxicity were comparable to G. polynesiensis, the most toxic species isolated to
date from the Pacific [70,71]. Due to its high MTX-toxicity, the aim of the present study was to
characterize the MTX congeners produced by G. excentricus and to determine if they were the same
or different from those previously identified. The approach was based on bioguided fractionation
of the aqueous methanol fraction containing MTXs using size-exclusion chromatography (LH-20).
Individual fractions were screened for MTX activity using the N2a cytotoxicity and Ca2+ flux functional
assays. The MTX positive fractions were subjected to chemical analyses (LC-HRMS, LC-HRMS/MS
and LC-LRMS/MS) to identify potential MTX congeners. Unfractionated methanolic extracts of a
total of 44 strains representing one species of Fukuyoa and 11 species, one ribotype and one strain of
Gambierdiscus whose species identity has yet to be determined were also screened at the same time.
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The results indicated G. excentricus produces a novel MTX congener, MTX4, which was not found in
any of the other species tested.
2. Results
2.1. Toxicity of the Aqueous Methanol Fractions (MSFs) from G. excentricus Strains VGO791 and VGO792
The toxicity of the aqueous MeOH soluble fractions (MSFs) of strains VGO791 and VGO792 from
the Canary Islands were assessed using the N2a cytotoxicity assay performed at the Phycotoxins
Laboratory (Ifremer, Nantes, France). The assay was calibrated using a purified MTX standard, which
induced mortality of the N2a cells in a concentration-dependent manner, with an EC50 of 158.5 ± 5.4
(SD, n = 3) ng MTX mL−1 (Figure S1). Strain VGO791 exhibited a toxin content of 0.65 ± 0.13 ng MTX
equivalents (eq) cell−1 and VGO792 a toxin content of 0.19 ± 0.05 ng MTX eq cell−1. Strain VGO791
was therefore 3.4-fold more toxic than VGO792. The results for VGO791 were in accordance with
a previous study conducted by Fraga et al. [61], which estimated the toxicity of this strain at
0.60 ± 0.24 MTX eq cell−1. In contrast, the toxicity estimated for VGO792 in the present study was
2.5-fold lower than that of 0.48 ± 0.16 ng MTX eq cell−1 obtained by Fraga et al. [61].
2.2. Screening of Fractionated G. excentricus Extracts Using Neuroblastoma N2a Assays
2.2.1. N2a Cytotoxicity Assay
The fractionation of the extracted MSF sample from strain VGO791 was accomplished using
size-exclusion chromatography (SEC, LH-20). The fractions containing MTX activity consistently
eluted within an elution volume (Ve) range of 12.5–27.5 mL. The most toxic fractions were found
in Ve = 15.0–17.5 mL (up to 58.8% total cytotoxicity) (Figure 2a). Similarly, toxic fractions from
strain VGO792 eluted in the range of Ve = 13.0–26.0 mL, with the most toxic fractions being
fraction Ve = 15.0–16.0 mL (up to 29.8% total cytotoxicity) and Ve = 16.0–17.0 mL (up to 23.3% total
cytotoxicity) (Figure 2b). Fractions of VGO792 corresponding to Ve = 23.0–26.0 mL showed slight
cytotoxic activity (N2a cell survival ~80–90%) only when the highest concentration of cell extracts
was tested (150 Gambierdiscus cell eq per well). Serial dilutions of the latter fractions contained no
detectable toxicity as measured using the N2a assay (N2a cell survival >90%). Consequently, sigmoidal
dose-response curves could not be plotted and EC50 values could not be calculated for quantification
purposes for the low toxicity fractions.
The N2a cytotoxicity assay showed that toxic compound(s) eluted right after the total exclusion
volume of the LH-20 column (i.e., approximately 30% of bed volume, 12.4 mL). LH-20 chromatography
separates compounds with MW ≤ 5000 Da according to their size (i.e., smaller compounds elute later
than bigger ones) meaning the toxic compound(s) from these strains are likely to fall in the range of
~3000–3500 Da, consistent with the molecular weight of MTX.
2.2.2. N2a Calcium Flux Assay
The N2a-based high-content screening (HCS) assay for calcium (Ca2+) flux was performed at the
ANSES Laboratory (Fougères, France). A Ca2+ flux assay was used in this study to measure changes in
internal Ca2+ concentration in N2a cells. The assay works by loading cells with a fluorescent dye, in this
case Fluo-4-AM, whose fluorescence changes as a function of intracellular Ca2+ (iCa2+) concentration.
Maitotoxin standard elicited an increase of iCa2+ in N2a cells in a concentration-dependent manner
(Figure S2). Since MTX induces influx of Ca2+ into cells, a significant increase in fluorescence is
consistent with the presence of MTX (Section 4.5.2). Results were expressed as a fold of intensity
compared to control treatment (5% MeOH in FCS-free N2a medium).
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represent assay variability (standard deviation, SD) measured by running extracts in three separate 
assays. In each assay, three separate wells were used for assaying each fraction. Cytotoxicity was 
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because no cytotoxicity was observed in those fractions. 
The crude extract (CE) and the MSF of G. excentricus VGO791 increased iCa2+ levels in N2a cells 
up to the saturation level (data not shown), indicating the presence of compounds exhibiting activity 
similar to MTX. Only the six LH-20 fractions of MSF falling within a Ve range of 12.5–27.5 mL 
showed an increase in iCa2+ levels of between 1.2- and 1.8-fold (Figure 3), suggesting that 
MTX-related compound(s) mostly eluted in these fractions. These findings are consistent with the 
results obtained by the N2a cytotoxicity assay (Section 2.2.1). 
Figure 2. Estimated maitotoxin equivalents (µg MTX eq) in the LH-20-fractionated MSFs of G.
excentricus strains VGO791 and VGO792 measured using the N2a cytotoxicity assay. (a) MTX eq
of the individual 2.5 mL-fractions for G. excentricus VGO791 (2.20 million cells extracted in original
MSF, approximately half of which was loaded on the LH-20 column). (b) MTX eq of the individual
1 mL-fractions for G. excentricus VGO792 (2.16 million cells extracted in original MSF, approximately
half of which was loaded on the LH-20 column). The x-axis is expressed as the total elution volume
(mL) that has passed through the LH-20 column when each fraction was collected. Error bars
represent assay variability (standard deviation, SD) measured by running extracts in three separate
assays. In each assay, three separate wells were used for assaying each fraction. Cytotoxicity was
observed only in LH-20 fractions within an elution volume (Ve) range of (a) Ve = 12.5–27.5 mL and (b)
Ve = 13.0–26.0 mL. Asterisks (*) in (b) indicate detection of non-quantifiable cytotoxicity in fractions
with Ve = 23.0–26.0 mL. Fractions corresponding to Ve < 10.0 mL and Ve > 30.0 mL are not shown
because no cytotoxicity was observed in those fractions.
The crude extract (CE) and the MSF of G. excentricus VGO791 increased iCa2+ levels in N2a
cells up to the saturation level (data not shown), indicating the presence of compounds exhibiting
activity similar to MTX. Only the six LH-20 fractions of MSF falling within a Ve range of 12.5–27.5 mL
showed an increase in iCa2+ levels of between 1.2- and 1.8-fold (Figure 3), suggesting that MTX-related
compound(s) mostly eluted in these fractions. These findings are consistent with the results obtained
by the N2a cytotoxicity assay (Section 2.2.1).
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Figure 3. Calcium (Ca2+) influx into N2a cells induced by LH-20 fractions of G. excentricus VGO791
(MSF sample). Ca2+ flux was measured using fluorescence of Fluo-4-AM (488 nm). Fluo-4-AM
fluorescence was expressed as a fold of intensity compared to the control wells (horizontal dashed line).
Error bars represent assay variability (standard deviation, SD) measured by running extracts in three
separate assays. In each assay, three separate wells were used for assaying each fraction. Ca2+ influx was
observed only in LH-20 fractions corresponding to an elution volume (Ve) of 12.5–27.5 mL. Fractions
eluting after a Ve of 30 mL were omitted because they exhibited no MTX-induced fluorescence changes.
2.3. Liquid Chromatography Coupled to Full-Scan High Resolution Mass Spectrometry and Discovery of a New
Maitotoxin Analog
The Molecular Feature Extraction (MFE) algorithm of the Agilent MassHunter Qualitative
Analysis software allows for retreatment of raw data of non-targeted HRMS analysis (Q-Tof 6550).
Extracted compound chromatograms acquired in negative ionization mode (negative ECCs) of
G. excentricus VGO791 confirmed that liquid-liquid partitioning and size-exclusion chromatography
purification steps considerably reduced data complexity. More than one thousand features were
detected in the crude extract, while only 40 features (3%) were present in the most toxic LH-20
fraction (Ve = 15.0–17.5 mL) (Figure 4). Similarly, MFE results for G. excentricus VGO792 also exhibited
a reduction of data complexity from more than five thousands features to only 239 (4.3%) in the
most toxic LH-20 fraction of MSF (Ve = 15.0–16.0 mL), data not shown. These results indicate that
fractionation via liquid-liquid partitioning and size-exclusion chromatography (LH-20) is a suitable
strategy for Gambierdiscus toxin purification. In particular, LH-20 is an efficient clean-up step for high
molecular weight compounds as it allows for sufficient purification for individual compounds to be
identified as potential MTX congeners.
Among the occurring negative ions present in the negative mode ECCs of the most toxic LH-20
fractions of G. excentricus VGO791 and VGO792, only one bi-charged anion presented, like MTX,
an m/z ratio >1500. This compound possesses a retention time close to that of MTX (∆RT = +0.49 min).
Interestingly, it was detected only in the most toxic LH-20 fractions of both strains (as well as
in their MSF and crude extract) and was not detected in non-toxic fractions. Thus, the presence
of this compound in toxic fractions only, along with similar MS and chromatographic behavior
as MTX, suggested that the compound could be a novel MTX analog and hence it was named
maitotoxin-4 (MTX4).
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Figure 4. Negative Extracted Compound Chromatograms (ECCs) of G. excentricus VGO791 samples:
(a) crude extract; (b) aqueous methanol soluble fraction (MSF); (c) the most toxic LH-20 fraction
(Ve = 15.0–17.5 mL) of MSF. The different color peaks represent unique features. The highlighted grey
arrow indicates the peak corresponding to maitotoxin-4 (MTX4).
2.4. Mass Spectral Comparison of Maitotoxin-4 with Maitotoxin
2.4.1. Negative Mode HRMS Spectra
Maitotoxin-4 (MTX4) had a sp ctral profile similar to MTX. Maitotoxin-4 spectra originate from
the pre-purified LH-20 fraction (Ve = 15.0–16.0 mL) of G. excentricus VGO792. he assigned negative
HRMS ion species (accurate mono-isotopic m/z) for MTX and MTX4 are listed in Table 2.
Both MTX and MTX4 presented: (i) bi-charged molecular anions [M − 2H]2−, with accurate
mono-isotopic m/z of 1688.8027 for MTX (∆ppm: −0.8) and 1645.2357 for MTX4 and (ii) tri-charged
molecular anions [M − 3H]3−, with accurate mono-isotopic m/z of 1125.5334 for MTX (∆ppm:
−1.4) and 1096.4889 for MTX4 (Figure 5a,b). Hence, MTX4 presents a lower mass than the MTX
standard: 3292.4860 (MTX accurate calculated mass, free acid form) versus 3379.6172 (MTX
theoretical exact mass, free acid form), ∆M = 87.1312. For MTX only, it was also possible to
observe the quadri-charged molecular anion [M − 4H]4−, with accurate mono-isot pic m/z of
843.8989 (∆ppm: −2.1) (Figure 5a). Further, the followin adducts (accurate mono-isotopic m/z)
could be assig ed: [M + Na − 3H]2− = 1699.7914 for MTX (∆ppm: +0.5) and 1656.2256 for MTX4;
[M + 2Na − 4H]2− = 1710.7814 for MTX (∆ppm: +1.1) and 1667.2075 for MTX4 (Figure 5a,b). In the
negative mode HRMS spectrum of MTX4, two additional peaks were observed, with accurate
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mono-isotopic m/z of 1356.6470 (z = 2, bi-charged anion) and 904.0954 (z = 3, tri-charged anion),
suggesting either that some fragmentation occurred in the ESI source or that co-elution occurred
during the chromatographic separation (Figure 5b).
Table 2. List of the assigned negative HRMS ion species for MTX and MTX4. MTX4 spectra originate
from the pre-purified LH-20 fraction (Ve = 15.0–16.0 mL) of G. excentricus VGO792. The m/z values in
the table correspond to the accurate mono-isotopic m/z. ND: not detected. UNKN: unknown.
MTX MTX4
Elemental formula (free acid form) C164H258O68S2 UNKN
Retention time (RT, min) 4.09 min 4.58 min
Ion species
(accurate mono-isotopic m/z)
[M − 2H]2− 1688.8027 (∆ppm: −0.8) 1645.2357
[M + Na − 3H]2− 1699.7914 (∆ppm: +0.5) 1656.2256
[M + 2Na − 4H]2− 1710.7814 (∆ppm: +1.1) 1667.2075
[M − 3H]3− 1125.5334 (∆ppm: −1.4) 1096.4889
[M − 4H]4− 843.8989 (∆ppm: −2.1) ND
Mar. Drugs 2017, 15, 220 9 of 31 
 
anion) and 904.0954 (z = 3, tri-charged anion), suggesting either that some fragmentation occurred in 
the ESI source or that co-elution occurred during the chromatographic separation (Figure 5b). 
Table 2. List of the assigned negative HRMS ion species for MTX and MTX4. MTX4 spectra originate 
from the pre-purified LH-20 fraction (Ve = 15.0–16.0 mL) of G. excentricus VGO792. The m/z values in 
the table correspond to the accurate mono-isotopic m/z. ND: not detected. UNKN: unknown. 
MTX MTX4
Elemental formula (free acid form) C164H258O68S2 UNKN 
Retention time (RT, min)  4.09 min 4.58 min 
Ion species  
(accurate mono-isotopic m/z) 
[M − 2H]2− 1688.8027 (Δppm: −0.8) 1645.2357 
[M + Na − 3H]2− 1699.7914 (Δppm: +0.5) 1656.2256 
[M + 2Na − 4H]2− 1710.7814 (Δppm: +1.1) 1667.2075 
[M − 3H]3− 1125.5334 (Δppm: −1.4) 1096.4889 
[M − 4H]4− 843.8989 (Δppm: −2.1) ND 
 
Figure 5. Raw spectra in full scan, negative ion acquisition mode HRMS of (a) maitotoxin (MTX) and 
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of G. excentricus VGO792. Note the presence of bi-charged and tri-charged ion clusters for both MTX 
and MTX4. Negative mode ESI product ion spectra of bi-charged molecular anions of (c) MTX and 
(d) MTX4 at an average of three collision energies (CE): 50, 100 and 200 eV over an m/z range from 25 
to 3200, focused on the m/z range from 25 to 1700. Note the same product ion [HOSO3]− for both MTX 
and MTX4. Nota bene: the m/z values highlighted in the figure correspond to the accurate, i.e., 
measured mono-isotopic m/z. 
Figure 5. Raw spectra in full scan, negative ion acquisition mode HRMS of (a) maitotoxin (MTX) and
(b) maitotoxin-4 (MTX4) acquired over an m/z range from 100 to 3200, focused on the m/z range from
800 to 1800. Maitotoxin-4 spectra originate from the pre-purified LH-20 fra tion (Ve = 15.0–16.0 mL)
of G. excentricus VGO792. Note the presen e f bi- h rged and tri-charged ion clusters for both MTX
and MTX4. Negative mode ESI product ion spectra of bi-charged molecular anions of (c) MTX and
(d) MTX4 at an average of three collision energies (CE): 50, 100 and 200 eV over an m/z range from
25 to 3200, focused on the m/z range from 25 to 1700. Note the same product ion [HOSO3]− for both
MTX and MTX4. Nota bene: the m/z values highlighted in the figure correspond to the accurate,
i.e., measured mono-isotopic m/z.
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2.4.2. Negative Mode HRMS/MS Spectra
Maitotoxin-4 (MTX4) was further analyzed using Collision Induced Dissociation in Q-Tof targeted
MS/MS mode (HRMS/MS). Maitotoxin-4 spectra originate from the pre-purified LH-20 fraction
(Ve = 15.0–16.0 mL) of G. excentricus VGO792. Accurate mass data and isotopic distributions for the
precursor and product ions of MTX4 were compared to spectral data of the reference compound, MTX,
obtained in identical experimental conditions.
HRMS/MS fragmentation of the bi-charged molecular anion ([M − 2H]2−) of MTX and MTX4
showed that the two molecules share the same product ion at an average m/z of 96.9593 ± SD 0.0003
(n = 4) when using a collision energy (CE) ≥ 100 eV (Figure 5c,d). This fragment corresponds to the
hydrogenated sulfate anion [HOSO3]− (∆ppm: +8.3). No other characteristic fragment ion has been
found at any of the collision energies tested.
2.5. Quantification of MTX4 via LC-LRMS/MS
The limit of detection (LOD) and the limit of quantification (LOQ) of the MRM transition
[M − 2H]2− → [M − 2H]2− of MTX chosen for quantification purpose, were, respectively,
0.64 µg mL−1 and 2.12 µg mL−1. LOD and LOQ of MTX4 were assumed being the same of MTX. The
LOD and the LOQ of the MRM transition [M − 3H]3− → [M − 3H]3− of MTX were, respectively,
0.12 µg mL−1 and 0.39 µg mL−1. As shown in Figure 5a, the tri-charged molecular anion of MTX
gave a more intense response than the bi-charged molecular anion in our analytical conditions.
Nevertheless, that was not the case for MTX4 (Figure 5b). Although the higher LOD and LOQ,
the MRM transition [M − 2H]2− → [M − 2H]2− was chosen for quantification instead of the MRM
transition [M − 3H]3− → [M − 3H]3−.
Table 3 presents the results of (i) the amount of MTX4 present in crude extracts from approximately
2.2 million cells of G. excentricus VGO791 and VGO792 and (ii) the amount of MTX4 remaining after the
subsequent liquid-liquid partitioning and LH-20 chromatography purification steps. The quantities of
MTX4 were estimated using multiple reaction monitoring (MRM) mode on LC-LRMS/MS as described
in Section 4.6.2. The amounts of MTX4 present were expressed as µg MTX eq, assuming an equimolar
response of MTX4 and MTX in MS. The efficiency of each purification step was expressed in percent
recovery relative to the amount of MTX in the crude extract. The combination of the two purification
steps allowed for a percent recovery of 72% for VGO791 and 70% for VGO792 if all the toxic fractions
with a concentration of MTX4 > LOQ were combined (Table 3).
Table 3. Amounts of MTX4 present in crude extract from approximately 2.2 million cells of G. excentricus
VGO791 and VGO792 and the amounts of toxin remaining after the subsequent liquid-liquid
partitioning and LH-20 chromatography purification steps. The MTX4 estimates were obtained using
multiple reactions monitoring (MRM) mode on LC-LRMS/MS. Quantification of MTX4 was based on
the MRM transition 1646.2→ 1646.2 m/z ([M − 2H]2− → [M − 2H]2−) using MTX as the reference
standard, quantified using the MRM transition 1689.8→ 1689.8 m/z ([M − 2H]2− → [M − 2H]2−).
Amounts of MTX4 were therefore expressed in µg MTX eq, assuming an equimolar response of MTX4
and MTX in MS. * MSF: aqueous methanol soluble fraction.







Crude extract 160.1 100%
Liquid-liquid partitioning of crude extract
MSF * 137.4 85.8%
Size-exclusion chromatography (LH-20) of MSF sample
Ve = 12.5–15.0 mL 19.1 13.9%
Ve = 15.0–17.5 mL 69.2 50.4%
Ve = 17.5–20.0 mL 19.0 13.8%
Ve = 20.0–22.5 mL 4.5 3.3%
Ve = 22.5–25.0 mL 1.5 1.1%
Ve = 25.0–27.5 mL 1.2 0.9%
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Crude extract 43.1 100%
Liquid-liquid partitioning of crude extract
MSF * 34.2 79.4%
Size-exclusion chromatography (LH-20) of MSF sample
Ve = 13.0–14.0 mL 0.6 1.7%
Ve = 14.0–15.0 mL 4.6 13.5%
Ve = 15.0–16.0 mL 10.3 30.1%
Ve = 16.0–17.0 mL 6.2 18.0%
Ve = 17.0–18.0 mL 3.3 9.6%
Ve = 18.0–19.0 mL 1.8 5.3%
Ve = 19.0–20.0 mL 1.2 3.4%
Ve = 20.0–21.0 mL 0.8 2.5%
Ve = 21.0–22.0 mL 0.6 1.9%
Ve = 22.0–23.0 mL 0.6 1.7%
Ve = 23.0–24.0 mL <LOQ
Ve = 24.0–25.0 mL <LOQ
Ve = 25.0–26.0 mL <LOQ
2.6. Relationship between N2a Cytotoxicity and MTX4 Content
The MTX contents of MSFs estimated via N2a cytotoxicity assay were: 1427 ± 289 µg MTX eq
for G. excentricus VGO791 (2.20 million cells) and 408 ± 110 µg MTX eq for G. excentricus VGO792
(2.16 million cells). This estimation is, respectively, 10.4- and 11.8-fold higher than the MTX4 content
estimated via LC-LRMS/MS (137.4 and 34.2 µg MTX eq, respectively, Section 2.5).
Six LH-20 fractions of VGO791 (Ve = 12.5–27.5 mL) and ten LH-20 fractions of VGO792
(Ve = 13.0–23.0 mL) contained measurable quantities of (i) MTX equivalent toxicity (µg MTX eq,
starting with an initial crude extract of ~2.2 million cells) as measured using the N2a cytotoxicity
assay (Section 2.2.1) and (ii) MTX4 (µg MTX eq) using LC-LRMS/MS (Section 2.5). Toxin content
estimated with the N2a cytotoxicity assay was plotted against MTX4 quantification performed using
LC-LRMS/MS. The linear correlation between the amount of MTX equivalents (N2a cytotoxicity assay)
and the MTX4 content (LC-LRMS/MS) among the 16 toxic LH-20 fractions (slope: 3.498, R2: 0.986,
n = 16) suggests that MTX4 is a major contributor agent for the MSF-toxicity of both G. excentricus
strains (Figure 6).
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Figure 6. Linear correlation between the MTX equivalents (N2a cytotoxicity assay) and the MTX4
content (LC-LRMS/MS) in all LH-20 fractions containing quantifiable amounts of the two strains of
G. excentricus VGO791 (n = 6) and VGO792 (n = 10). Results are expressed in µg MTX eq, assuming
an equimolar response of MTX4 and MTX in MS. Error bars represent assay variability (standard
deviation, SD) measured by running extracts in three separate assays. In each of these assays, three
separate wells were used for assaying each fraction. The MTX4 LC-LRMS/MS determinations were
not replicated.
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2.7. Diversity of MTX Analogs among Gambierdiscus and Fukuyoa Strains
A total of two strains of Fukuyoa (one species, F. ruetzleri) and 42 strains of Gambierdiscus
representing 11 species, one ribotype and one strain of Gambierdiscus whose identity has yet to
be determined, were screened for the presence of MTX analogs using the LC-LRMS/MS conditions
described in Section 4.6.2.
The LC-LRMS/MS method consisted of searching for several MRM transitions of different parent
ions pointing towards the hydrogenated sulfate anion [HOSO3]− (96.9 m/z). The parent ions for MTX
and MTX4 were chosen from the negative ionization mode HRMS analysis conducted in this study
(Section 2.4.1). More precisely, the third isotopic peak (M + 2) was chosen because it was the most
intense (i.e., 1689.8 m/z and 1126.2 m/z for MTX and 1645.2 m/z and 1097.1 m/z for MTX4). In the
absence of MS/MS data on MTX2 and MTX3, parent ions were selected from the literature [56,72].
For MTX2, bi-charged and tri-charged adducts with Na+ and K+ have been reported in a previous
study [56] and these have been used for LRMS/MS analysis. Furthermore, the bi-charged and
tri-charged molecular anions have been searched assuming similar MS behavior of MTX4 compared to
MTX. Thus, both molecular ([M − 2H]2− and [M − 3H]3−) and pseudomolecular anions (i.e., Na+ and
K+ adducts) have been searched for. Maitotoxin-3 is assumed to be di-sulfated [56] and was tentatively
detected in previous studies using the loss of sulfate from the mono-charged mono-sodium adduct,
i.e., the MRM transition [M + Na − 2H]− → [HOSO3]− (m/z 1037.6→ 96.9) [59,64,66,71–74]. With the
aim of increasing selectivity, in this study the mono-charged and bi-charged molecular anions, as well
as the mono-charged di-sodium adduct have been searched for, assuming similar MS behavior as that
of MTX and MTX4 (Section 4.6.2).
Results are summarized in Table 4. Limits of detection (LODs) in Table 4 have been calculated
from the number of cells extracted, specified in Table 5. Maitotoxin was found only in one strain,
G. australes S080911_1, at a concentration of 22.6 ± 0.5 pg MTX cell−1. Maitotoxin-4 was found in all
seven G. excentricus strains examined (13–72.8 pg MTX eq cell−1), independently of their geographical
origin (Table 4).
MRM transitions of bi-charged anions (1637.5, 1648.2, 1656.0 m/z) of MTX2 towards the [HOSO3]−
(96.9 m/z) were not found in any of the strains examined. Putative MTX2 identified using 1091.5
and/or 1103.8 tri-charged anions as parent ions was found in G. caribaeus, G. excentricus, G. pacificus
and Gambierdiscus sp. Viet Nam. HRMS analyses conducted on the most concentrated samples
(G. excentricus strains, G. pacificus G10-DC and Gambierdiscus sp. Viet Nam) unveiled that peaks found
in LRMS/MS for MTX2 were actually false positives: 1091.5 was indeed a mono-charged ion species,
so it could not be the molecular tri-charged anion [M − 3H]3− estimated for MTX2. HRMS analyses
also revealed very similar RT and MS/MS spectra for the peak with a nominal mass of 1091.5 in the
two strains G. pacificus G10-DC and Gambierdiscus sp. Viet Nam, even though they had a different
accurate mass. Additionally, the compound with a similar nominal mass of 1091.5 had a different RT
and HRMS/MS fragmentation pathway in the G. excentricus strain Pulley Ridge Gam2 (Figure 7).
Putative MTX3 analogs were found in all Fukuyoa and Gambierdiscus strains examined. LRMS/MS
already suggested at least two different compounds with m/z = 1037.6, i.e., one compound present in
all G. excentricus strains (RT = 4.0–4.1 min) and one in some strains of other species (RT = 4.8–4.9 min)
(Table 4). HRMS analyses confirmed the differences between G. excentricus strains and all the other
strains (G. australes VGO1178, CCMP1653 and S080911_1; G. balechii VGO917 and VGO920; G. caribaeus
CCMP1733 and Bill Hi Gam8; G. carpenteri GT4 and WHBR21; G. pacificus CCMP1650; G. scabrosus
KW070922_1) (Figure 8).
For G. excentricus species, LH-20 fractionation of VGO791 and VGO792 showed no
correlation between the cytotoxicity observed and the peak intensities corresponding to p-MTX2
(Ve = 21.0–34.0 mL) and p-MTX3 (Ve = 16.0–29.0 mL) analogs but only with MTX4 (Section 2.6).
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Figure 7. False positives for MTX2. Negative electrospray chromatogram, HRMS spectra and averaged
HRMS/MS spectra (CEs = 25, 50 and 75 eV) of 1091.5 m/z found in crude extracts of: (a) G. pacificus
G10-DC, (b) Gambierdiscus sp. Viet Nam and (c) G. excentricus Pulley Ridge Gam2.
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Figure 8. Putative candidates for MTX3. Negative electrospray chromatogram, HRMS spectra and
averaged HRMS/MS spectra (CEs = 50, 100 and 150 eV) of 1037.5 m/z found in crude extracts of
(a) G. excentricus VGO792, used as example for all G. excentricus strains; (b) G. australes S080911_1, used
as example for all G. australes, G. balechii, G. caribaeus, G. carpenteri, G. pacificus, G. scabrosus strains.
HRMS/MS spectra are presented with a zoom on an m/z range from 900 to 1020. * = peak only
observed due to large mass window in quadrupole filter of HRMS/MS.
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Table 4. Screening for the presence of MTX analogs in crude extracts of a total of 44 strains of Gambierdiscus and Fukuyoa using LC-LRMS/MS analysis. MTX4 content
is expressed in pg MTX eq cell−1, assuming an equimolar response of MTX4 and MTX in MS. RT: retention time. ND: not detected. *: only one replicate available.
LOD for MTX and MTX4 per sample is indicated in parenthesis and it is expressed in pg MTX eq cell−1. LODs were calculated according to the number of cells
extracted for each strain (Table 5).
Species Strain
MTX p-MTX2 p-MTX3 MTX4
pg MTX cell−1
± SD (n = 3)
RT = 4.64 min
1091.5→ 96.9 1103.8→ 96.9 1015.5→ 96.9 1037.6→ 96.9
pg MTX eq cell−1
± SD (n = 3)
RT = 5.05 min
F. ruetzleri
Gam1 ND (<2.97) ND ND ND RT = 4.89 & 5.74 ND (<2.97)
WH55-Gam4 ND (<4.97) ND ND ND RT = 4.88 ND (<4.97)
G. australes
CCMP1653 (NOAA 24) (T39) ND (<1.54) ND ND ND RT = 4.86 ND (<1.54)
S080911_1 22.6 ± 0.5 ND ND ND RT = 4.86 ND (<0.80)
VGO1178 ND (<2.46) ND ND ND RT = 4.87 ND (<2.46)
VGO1181 ND (<2.22) ND ND ND RT = 4.87 ND (<2.22)
G. balechii
VGO917 ND (<1.66) ND ND RT = 4.10 & 4.21 RT = 4.80 ND (<1.66)
VGO920 ND (<2.02) ND ND RT = 3.94 RT = 4.86 ND (<2.02)
G. belizeanus
CCMP399 (NOAA2) (SB03) ND (<3.51) ND ND ND RT = 4.80 ND (<3.51)
Keys Gam1 ND (<7.79) ND ND ND RT = 4.80 ND (<7.79)
ST1-F4 ND (<6.20) ND ND ND RT = 4.83 ND (<6.20)
G. caribaeus
CCMP1733 (NOAA11) ND (<2.27) RT = 3.64 & 4.28 RT = 3.64 & 4.28 ND RT = 4.84 ND (<2.27)
Bill Hi Gam8 ND (<5.79) RT = 4.05 & 4.30 RT = 4.05 & 4.30 ND RT = 4.83 ND (<5.79)
CCMP1651 (NOAA20) ND (<10.27) RT = 4.27 RT = 4.27 ND RT = 4.82 ND (<10.27)
Dive 1 fa Gam1 ND (<1.69) RT = 4.26 RT = 4.26 ND RT = 4.83 ND (<1.69)
Mexico Algae1 Gam1 ND (<5.19) RT = 4.27 RT = 4.27 ND RT = 4.80 ND (<5.19)
G. carolinianus
ETB Exp28 Gam10 ND (<10.49) ND ND RT = 4.55, 6.11 & 6.21 RT = 4.89, 6.11 & 6.21 ND (<10.49)
Greece Gam2 ND (<7.73) ND ND RT = 4.54 & 6.21 RT = 4.86, 6.21 & 7.17 ND (<7.73)
RROV5 ND (<5.47) ND ND RT = 5.12 & 6.25 RT = 5.12 & 6.25 ND (<5.47)
G. carpenteri
GT4 ND (<7.27) ND ND ND RT = 4.86 ND (<7.27)
Jamaica Algae2 Gam1 ND (<6.51) ND ND ND RT = 4.81 ND (<6.51)
Pat Hi Jar7 Gam11 ND (<10.72) ND ND ND RT = 4.86 ND (<10.72)
WHBR21 ND (<6.62) ND ND ND RT = 4.84 ND (<6.62)
G. excentricus
Pulley Ridge Gam 2 ND (<0.39) RT = 5.68 ND ND RT = 4.01 22.9 *
UNR-07 ND (<0.63) RT = 5.64 ND ND RT = 4.05 16.0 ± 2.3
UNR-08 ND (<1.45) RT = 5.68 ND ND RT = 4.05 19.8 ± 6.4
VGO1035 ND (<2.64) RT = 5.68 ND ND RT = 4.01 13.0 *
VGO790 ND (<3.73) RT = 5.67 ND ND RT = 4.01 23.2 *
VGO791 ND (<0.29) RT = 5.67 ND ND RT = 3.71 & 4.01 72.8 ± 8.5
VGO792 ND (<0.30) RT = 5.68 ND ND RT = 3.68 & 3.99 20.0 ± 2.9
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Table 4. Cont.
Species Strain
MTX p-MTX2 p-MTX3 MTX4
pg MTX cell−1
± SD (n = 3)
RT = 4.64 min
1091.5→ 96.9 1103.8→ 96.9 1015.5→ 96.9 1037.6→ 96.9
pg MTX eq cell−1
± SD (n = 3)
RT = 5.05 min
G. pacificus CCMP1650 (NOAA 9) (MR1) ND (<1.02)
RT = 5.33, 6.06,
6.24 & 6.82
RT = 5.33, 6.06,
6.24 & 6.82 ND RT = 4.89 ND (<1.02)
G10DC ND (<0.66) RT = 5.06 ND RT = 3.90 & 4.15 - ND (<0.66)
Gambierdiscus sp.
ribotype 2
CCMP1655 (MQ2) ND (<5.87) ND ND ND RT = 4.83 ND (<5.87)
Mixed PR ND (<6.49) ND ND ND RT = 4.90 ND (<6.49)
St Maartens Gam10 ND (<5.52) ND ND ND RT = 4.90 ND (<5.52)
SW Algae Gam1 ND (<8.38) ND ND ND RT = 4.81 ND (<8.38)
G. scabrosus KW070922_1 ND (<0.83) ND ND ND RT = 4.80 ND (<0.83)
G. silvae
UNR-30 ND (<1.76) ND ND RT = 5.93 & 6.13 RT = 3.22, 4.76, 5.35,5.93, 6.13, 6.98 ND (<1.76)
VGO1167 ND (<1.27) ND ND - RT = 4.83 ND (<1.27)
VGO1180 ND (<1.52) ND ND RT = 5.92 & 6.14 RT = 4.68, 5.92 & 6.14 ND (<1.52)
Gambierdiscus sp. Viet Nam ND (<0.37) RT = 5.14 ND RT = 7.02 RT = 7.64 ND (<0.37)
G. toxicus
GTT-91 ND (<5.49) ND ND RT = 2.94 RT = 4.89 ND (<5.49)
HIT-0 ND (<6.00) ND ND RT = 2.92 RT = 4.89 ND (<6.00)
HIT-25 ND (<8.56) ND ND RT = 2.90 RT = 4.88 ND (<8.56)
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3. Discussion
3.1. Gambierdiscus excentricus and the Discovery of Maitotoxin-4
Recent studies showed G. excentricus as one of the most toxic species known to date, both for
CTXs and MTXs [61,69,75]. The species was first described in the Canary Islands [61], a subtropical
region (North-Eastern Atlantic Ocean) from which Ciguatera Fish Poisoning (CFP) has recently been
reported [76,77]. Subsequently, it has also been found in Brazil [78,79] and in the Caribbean Sea [75].
The aim of the present study was to identify maitotoxin or analogs produced by this species using
high resolution mass spectrometry (HRMS).
Several difficulties had to be surmounted in the present study to identify such analogs. While the
N2a cytotoxicity assay allowed for MTX detection at ng mL−1 levels, comparable to what had been
reported by Caillaud, et al. [80], Q-Tof LC-HRMS (negative ion acquisition mode) had dramatically
poorer sensitivity, with an LOD for MTX at 1.88 µg mL−1. The LOD of MTX using HRMS was
relatively high compared to the LOD reported for LRMS [3]. However, as MTX itself was not present,
an untargeted approach based on full-scan HRMS was necessary to screen for any potential analogs
present, and the lower sensitivity of this technique had to be accepted. Compared to the need for µg
quantities of toxin for LC-HRMS analysis, maitotoxic species only produce up to ca. 80 pg MTX eq
cell−1 [69]. Hence, it was necessary to have a substantial biomass for purification purposes in order to
obtain detectable amounts of toxin. Gambierdiscus excentricus is difficult to cultivate compared to other
algae, including other Gambierdiscus species [69,75]. This is challenging because Gambierdiscus species
grow extremely slowly (0.08–0.10 divisions day−1) compared to most other microalgae [69,75,81,82].
Hence, large-scale cultures of the Canary Island strains VGO791 and VGO792 were necessary to obtain
sufficient material (>2 million cells) for LC-HRMS analysis.
Once sufficient biomass was obtained, toxicity screening (N2a-based assays) was applied to identify
toxic fractions following liquid-liquid partitioning and LH-20 chromatography. Results of both N2a
cytotoxicity and Ca2+ flux assays on LH-20 fractions suggested that G. excentricus strains produce
compound(s) with relatively high molecular weight (early elution on LH-20) and Ca2+-related activity
(N2a assays), similar to MTX. Chemical analyses using LC-HRMS (full scan mode) and LC-HRMS/MS
(targeted mode) led to the discovery of a novel MTX analog, named maitotoxin-4 (MTX4), a sulfated
compound with an accurate mono-isotopic mass of 3292.4860 Da (for the free acid form). No MTX2 was
detected in any of the seven strains of G. excentricus, and, additionally, toxicity in LH-20 fractions was not
correlated to putative MTX3. Therefore, and even though MTX4 was not yet completely purified, the
correlation between MTX4 content in pre-purified fractions and their N2a cytotoxicity (Figure 6) supports
the hypothesis that MTX4 is a major contributor to the toxicity of the MSF fraction of G. excentricus.
MTX equivalents measured in LH-20 fractions of both strains of G. excentricus, using the
N2a cytotoxicity assay (Section 2.6), were 3.5-fold higher than the MTX4 content measured via
LC-LRMS/MS for an equivalent number of extracted cells. This factor of 3.5 does not necessarily
indicate that the toxin content is overestimated using the cytotoxicity assay as the following
assumptions were made: (i) MTX4 exhibits the same toxicity as MTX and (ii) MTX and MTX4 have
the same behavior in MS, i.e., that they have an equimolar response. The relative toxicity between the
two molecules is not yet known, and neither are their ionization and fragmentation yields known in
MS. Furthermore, as suggested by Lewis et al. [57] for several other Gambierdiscus species, additional
analogs of MTX4 may be present in the same LH-20 fractions, albeit at lower concentration as we were
not able to identify such analogs by HRMS.
3.2. Screening for the Presence of Other MTX Analogs
Another aim of the present study was to assess the diversity of previously reported MTX analogs
produced by different strains and species of the genera Gambierdiscus and Fukuyoa. In order to achieve
this goal, an LC-LRMS/MS method (API 4000 QTrap) was developed to screen for the presence of four
MTX analogs in the extracts of two strains of F. ruetzleri and 42 strains representing 11 species, one
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ribotype and one strain of undetermined species (Gambierdiscus sp. Viet Nam) of Gambierdiscus spp.
(Section 4.6.2).
Previous LC-LRMS/MS studies conducted by a group from the Cawthron Institute [59,64,66,71–74]
evaluated the presence of MTX and putative MTX3 in a total of 32 strains of Gambierdiscus and Fukuyoa, i.e.,
two strains of F. cf. yasumotoi, 13 strains of G. australes, one strain of G. belizeanus, one strain of G. carpenteri,
two strains of G. cheloniae, two strains of G. honu, six strains of G. lapillus, four strains of G. pacificus and one
strain of G. polynesiensis. These authors reported that MTX was only present in 11 out of 13 G. australes
strains (0.3–36.6 pg MTX cell−1), one originating from Cook Islands [71] and the other ten from Kermadec
Islands [74]. In our present study, MTX was only detected in the one strain of G. australes (S080911_1)
from Japan, at a concentration of 22.6 pg MTX cell−1, also confirmed by LC-HRMS. The other three strains
of G. australes examined in this study (CCMP1653, from Hawaii; VGO1178 and VGO1181, from Canary
Islands) did not contain detectable (>LOD) levels of MTX. This absence of MTX in the other strains may
derive from comparatively high LODs around 1/10th of the concentration of MTX detected in the G.
australes strain from Japan. Still, this finding is consistent with previous studies in suggesting that MTX
itself has been mostly confirmed in strains of G. australes, at least since the most recent taxonomic separation
into species and phylotypes. Again, chemical diversity in G. australes may also be larger than reported until
now since Lewis et al. [57] reported at least two compounds with Ca2+ flux activity in a strain of G. australes.
Maitotoxin-4 was produced by all strains of G. excentricus examined in this study (13.0–72.8 pg
MTX eq cell−1) (Table 4), independently of their geographical origin, albeit all seven from the Atlantic
Ocean (Brazil, Canary Islands and Caribbean Sea), and was not detected in any other species examined.
These findings suggest that the production of certain MTX analogs is likely to be species-specific within
Gambierdiscus and Fukuyoa genera.
While results were clear and consistent with previous studies for MTX and MTX4, further
examination is needed concerning MTX2 and MTX3. Maitotoxin-2 was described only once, in 1990,
from an Australian strain of Gambierdiscus sp. (NQ1) by Holmes et al. [55]. To our knowledge,
no LC-MS/MS method has been described for the detection of MTX2, set aside one study by
Lewis et al. [56], which reported negative ionspray MS data based on infusion (using an orifice
voltage of -120 V) of MTX2 dissolved in MeOH:H2O (1:1, v/v). The assigned negative ion species for
the most intense MS peaks were: 1648.2 m/z for [M + Na − 3H]2−, 1656.0 m/z for [M + K − 3H]2−,
1098.6 m/z for [M + Na − 4H]3− and 1103.8 m/z for [M + K − 4H]3−. MTX2 is assumed to be a
mono-sulfated compound [53,56]. In the absence of MS fragmentation data for maitotoxin-2 (MTX2),
the MRM transitions chosen in this study were based on bi-charged and tri-charged molecular anions
and their respective sodium and potassium adducts pointing towards the hydrogenated sulfate anion
[HOSO3]−. Therefore, analysis additionally included 1091.5 m/z for [M − 3H]3− and 1637.5 m/z for
[M − 2H]2−, derived from analogy with spectral behavior observed for MTX and MTX4. None of the
strains presented a chromatographic peak with both bi- and tri-charged anion clusters in the mass
spectrum. All strains of several species (G. caribaeus, G. excentricus, G. pacificus and Gambierdiscus sp.
Viet Nam) were positive for the anion cluster of the nominal mass 1091.5 (which could potentially
correspond to [M − 3H]3− of MTX2). HRMS unveiled that these compounds were false positives of
MTX2: the parent ion 1091.5 is actually a mono-charged ion species in G. excentricus strains, G. pacificus
G10-DC and Gambierdiscus sp. Viet Nam (not sufficient sample material for G. caribaeus). Therefore,
low resolution MS may misidentify these compounds for MTX2 in several species. Moreover, different
retention time, accurate mass and HRMS/MS fragmentation pattern also revealed that the sulfated
compound with an m/z 1091.5 found in G. excentricus strains was different from those found in
G. pacificus G10-DC and Gambierdiscus sp. Viet Nam (Figure 7).
Maitotoxin-3 was isolated in 1994 from an Australian strain of Gambierdiscus sp. (WC1/1) by
Holmes, et al. [53]. The only existing MS data are from positive ionspray MS analysis at different
orifice potentials [56]. The authors described MTX3 as a disulfated compound (MW = 1060.5 Da for
the disodium salt), with the most intense MS peak at 1039.5 m/z for the mono-sodiated adduct [M +
Na]+ [56]. The only existing LC-LRMS/MS method for MTX3 detection has been developed by Kohli
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at the Cawthron Institute (Nelson, New Zealand) in 2013 and uses negative ionization mode [72]. This
method identified a putative MTX3 (p-MTX3) based on the MRM transition m/z 1037.6→ 96.8. The
parent ion at 1037.6 m/z had been incorrectly assigned to [M − H]− by Kohli [72]; indeed, according
to the original study [56], it actually corresponds to [M + Na − 2H]−. All but one (G. carpenteri
Merimbula) out of the 32 strains examined by the group of the Cawthron Institute were positive for
the presence of p-MTX3 [59,64,66,71–74]. All the strains examined in this present study were also
positive for the presence of p-MTX3, suggesting that p-MTX3 is ubiquitous within Gambierdiscus and
Fukuyoa genera. Interestingly, the parent ion chosen for p-MTX3 ([M + Na − 2H]−) has the same
nominal m/z as that for 2,3-dihydroxyCTX3C in negative ionization MS after loss of one molecule
of water (m/z 1037.5 for [M – H − H2O]−). 2,3-dihydroxyCTX3C is considered to be an oxidation
product of CTX3C and has extensively been found in Gambierdiscus [80,83]. In one study, conducted
by Roeder et al. [83], however, it had been the only analog present in ten out of a total of eleven
Gambierdiscus strains, and this study also used low resolution negative ionization MS. It is surprising
that CTX3C had not been detected in that study along with 2,3-dihydroxyCTX3C, except for one strain
(Gambierdiscus sp. Viet Nam). Therefore, we presume that this study by Roeder et al. [83] may have
misidentified 2,3-dihydroxyCTX3C, as it is likely that the actual compound present was the ubiquitous
p-MTX3. Therefore, we recommend that when attempting to detect 2,3-dihydroxyCTX3C in negative
mode LRMS/MS to verify that the compound does not have a loss of sulfate since this points towards
p-MTX3 rather than 2,3-dihydroxyCTX3C. In our study, the tentative identification of p-MTX3 involved
different possible parent ions (in some cases 1037.6, on other occasions 1015.5, and sometimes both)
with different retention times, therefore different compounds were present that could be tentatively
related to MTX3. HRMS/MS analyses for the most concentrated samples confirmed presence of
sulfate ester group(s) in these compounds which is coherent with these compounds responding to the
transition of the sulfate loss in low resolution tandem MS. At least one of the compounds, i.e., the one
identified in all G. excentricus strains, does not correlate with cytotoxicity which suggests that this
potential MTX analog is not important in accounting for toxicity.
It should also be noted that Gambierdiscus species produce other polyether compounds besides
MTX containing sulfate ester group(s). Consequently, the presence of sulfate ester group(s) alone does
not constitute definitive evidence for the presence of MTX. For example, a recent study conducted
by Rodríguez, et al. [84] reported on the isolation and structural characterization (HRMS and NMR)
of gambierone (C51H76O19S, with an exact mass of 1024.47015 Da) from G. belizeanus CCMP401.
This molecule is a ladder-shaped polyether toxin and presents a sulfate ester group, but, contrarily
to MTX, it behaves as a sodium channel activator such as CTXs, albeit with significantly smaller
activity. Similarly, Watanabe, et al. [85] reported on the structural elucidation (HRMS and NMR) of
gambieroxide (C60H90O22S, with an exact mass of 1194.5644), another sulfate-containing polyether
compound isolated from G. toxicus GTP-2 (French Polynesia). Its chemical structure is very similar to
that of yessotoxin (YTX); its biological activity has not yet been described.
Care should be taken in compound identification when operating in low-resolution mass
spectrometry, especially when the standard is not commercially available and when searching for
non-specific MRM transitions. In the present study, purification of MTX4 has not been completed and it
was not possible to elucidate the full structure due to compound scarcity. Still, the evidence presented
here for MTX4 as a MTX analog is based on (i) ion cluster similarity of MTX4 with MTX, (ii) targeted
HRMS (loss of sulfate), (iii) bioguided fractionation behavior (both partitioning and size-exclusion
chromatography), and (iv) the high cytotoxicity and Ca2+ influx activity. These data taken together
strongly suggest that the novel molecule is a MTX analog. As MTX4 is a compound correlated with
high cytotoxicity and could serve as a biomarker for the highly toxic G. excentricus species in the
Atlantic area, further studies will focus on HRMS specific fragmentation pathways of MTX and MTX4,
in both positive and negative ionization modes, and eventually nuclear magnetic resonance once
sufficient compound is available.
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4. Materials and Methods
4.1. Reference Toxins and Chemicals
Maitotoxin (MTX) was purchased from Wako Chemicals USA, Inc. (Richmond, VA, USA) and was
used as the reference standard for cellular bioassays and chemical analyses. MTX was dissolved and
stored in MeOH:H2O (1:1, v/v). The stock solution was prepared at a concentration of 20 µg mL−1.
HPLC grade methanol and dichloromethane for extraction were purchased from Sigma Aldrich
(Saint Quentin Fallavier, France). Milli-Q water was supplied by a Milli-Q integral 3 system (Millipore,
Saint-Quentin-Yvelines, France). Water (Optima quality), acetonitrile (Optima quality), formic acid
(Puriss quality) and ammonium formate (Purity for MS) were used to prepare mobile phases. These
chemicals were purchased from Sigma Aldrich (Saint Quentin Fallavier, France).
Eagle’s Minimum Essential Medium (EMEM, ATCC® 30-2003) for culture of mouse neuroblastoma
neuro-2a (N2a) cells at the Phycotoxins Laboratory was purchased from the American Type
Culture Collection (ATCC). Roswell Park Memorial Institute 1640 medium supplemented with
glutamine (RPMI-1640-GlutaMAX™) for culture of N2a cells at the ANSES Laboratory was
purchased from Thermofisher Scientific (Waltham, MA, USA). The following additives to the
N2a medium were purchased from Sigma Aldrich (Saint Quentin Fallavier, France): sodium
pyruvate, streptomycin, penicillin and fetal bovine serum (Phycotoxins Laboratory) or fetal calf
serum (ANSES Laboratory). N2a assay reagents were also purchased from Sigma Aldrich
(Saint Quentin Fallavier, France): trypsin-(ethylenediaminetetraacetic acid) (trypsin-EDTA) and
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT). Fluo-4-AM and Hoechst 33342
probes for the N2a Ca2+ flux high-content screening (HCS) assay were purchased from Thermofisher
Scientific (Waltham, MA, USA).
4.2. Gambierdiscus and Fukuyoa Strains Examined in This Study
The 44 strains of Gambierdiscus and Fukuyoa, which were examined in this study, and their location
of origin, culture conditions and number of cells extracted are listed in Table 5. Strains were cultivated
either at the Phycotoxins Laboratory (PHYC, Ifremer, Nantes, France) [69], or at the Center for Coastal
Fisheries Habit Research Laboratory (CCFHR, NOAA, Beaufort, NC, USA) [75], or at the University of
Rio (UNIRIO, Federal University of Rio de Janeiro State, RJ, Brazil) [79].
4.3. Cell Pellet Extraction
Cell pellets of Gambierdiscus and Fukuyoa strains were extracted three times with MeOH (30 mL
per 1 million cells) using a 3 mm diameter probe sonicator (Q-Sonica, Q700, Newtown, CT, USA) at
30% of the total power (500 W). The sonication was conducted in an ice bath (0 ◦C) for 15 min in
pulse mode (10 s ON, 5 s OFF). At the end of each sonication step, the supernatant (crude extract) was
collected by centrifugation (4 ◦C, 10 min, 4000 g). Crude extracts were filtered through a Nanosep MF
0.2 µm filter and stored at −20 ◦C until LC-MS analyses.
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Table 5. List of the two Fukuyoa and 42 Gambierdiscus strains examined in this study along with their species designation, geographical origin, culture collection of
origin, culture conditions, number of cells extracted for toxin analysis and the references where the strains have been previously cited. CCFHR: National Oceanographic
and Atmospheric Administration (NOAA), National Ocean Service, National Centers for Coastal Ocean Science, Center for Coastal Fisheries Habit Research (CCFHR),
Beaufort, NC, USA; CCVIEO: Culture Collection of Harmful Microalgae of IEO (CCVIEO), Centro de Vigo, Vigo, Spain; IRTA: Investigación y tecnología agroalimentarias,
Department of Agriculture, Government of Catalonia, Sant Carles de la Ràpita, Spain; KU: Kochi University (KU), Kochi, Japan; NCMA: Provasoli—Guillard National
Center for Marine Algae and Microbiota (NCMA), Bigelow Laboratory for Ocean Sciences, East Boothbay, Maine, USA; UNIRIO: Rio de Janeiro State, Federal University
(UNIRIO), Rio de Janeiro, RJ, Brazil; VNIO: Viet Nam National Institute of Oceanography (VNIO, VAST), Vinh Nguyen, Nha Trang, Viet Nam.






Gam1 Southwater Cay, Belize CCFHR CCFHR 215,190 [57,68]
WH55-Gam4 Flower Garden Banks National Marine Sanctuary (West Bank),Northwestern Gulf of Mexico, United States of America CCFHR CCFHR 128,800 [75]
G. australes
CCMP1653 (NOAA 24) (T39) Tern Island, Hawaii, United States of America NCMA PHYC 416,220 [58,86]
S080911_1 Kutsu, Susaki, Kochi, Japan KU PHYC 798,285 [87]
VGO1178 Punta Hidalgo, Tenerife, Canary Islands, Spain CCVIEO PHYC 260,388 [62,69]
VGO1181 Punta Hidalgo, Tenerife, Canary Islands, Spain CCVIEO PHYC 288,608 [69]
G. balechii
VGO917 Manado, Celebes Sea, Indonesia CCVIEO PHYC 384,650 [60,88]
VGO920 Manado, Celebes Sea, Indonesia CCVIEO PHYC 317,600 [60]
G. belizeanus
CCMP399 (NOAA2) (SB03) St. Barthélemy Island, Caribbean, Territorial collectivity ofSaint-Barthélemy NCMA PHYC 182,495 [57,58]
Keys Gam1 Florida Keys, Florida, United States of America CCFHR CCFHR 82,125 [68]
ST1-F4 St. Thomas, US Virgin Islands, United States of America CCFHR CCFHR 103,300 [68]
G. caribaeus
CCMP1733 (NOAA11) Carrie Bow Cay, Belize, Caribbean, United States of America NCMA PHYC 282,450 [58]
Bill Hi Gam8 Waikiki Beach, Honolulu, Hawaii, United States of America CCFHR CCFHR 110,600 [69]
CCMP1651 (NOAA20) Grand Cayman Island, Caribbean, Territory of UnitedKingdom NCMA CCFHR 62,300 [58]
Dive 1 fa Gam1 Ft. Pierce, Florida, United States of America CCFHR CCFHR 378,000 [68]
Mexico Algae1 Gam1 Cancun, Mexico CCFHR CCFHR 123,395 [68]
G. carolinianus
ETB Exp28 Gam10 Dry Tortugas, United States of America CCFHR CCFHR 61,005 [68]
Greece Gam2 Crete, Greece CCFHR CCFHR 82,775 [69]
RROV5 Puerto Rico, United States of America CCFHR CCFHR 116,985 [68]
G. carpenteri
GT4 Carrie Bow Cay, Belize CCFHR CCFHR 88,000 [57,68]
Jamaica Algae2 Gam1 Ocho Rios, Jamaica CCFHR CCFHR 98,250 [68]
Pat Hi Jar7 Gam11 Waikiki Beach, Honolulu, Hawaii, United States of America CCFHR CCFHR 59,680 [57,69]
WHBR21 Flower Garden Banks National Marine Sanctuary (West Bank),Northwestern Gulf of Mexico, United States of America CCFHR CCFHR 96,720 [68]
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Pulley Ridge Gam 2 Pulley Ridge, Florida, United States of America CCFHR CCFHR 1,630,000 [75]
UNR-07 Armação dos Búzios, Rio de Janeiro, Brazil UNIRIO UNIRIO 1,013,833 [79]
UNR-08 Armação dos Búzios, Rio de Janeiro, Brazil UNIRIO UNIRIO 441,490 [79]
VGO1035 Playa Las Cabras, La Palma, Canary Islands, Spain) CCVIEO PHYC 242,050 [61]
VGO790 Punta Hidalgo, Tenerife, Canary Islands, Spain CCVIEO PHYC 171,711 [61]
VGO791 Punta Hidalgo, Tenerife, Canary Islands, Spain CCVIEO PHYC 2,200,160 [61]
VGO792 Punta Hidalgo, Tenerife, Canary Islands, Spain CCVIEO PHYC 2,159,997 [61]
G. pacificus CCMP1650 (NOAA 9) (MR1) Moorea, Society Islands, French Polynesia NCMA PHYC 630,175 [58]
G10DC Malaysia IRTA PHYC 965,040 [80]
Gambierdiscus sp.
ribotype 2
CCMP1655 (MQ2) Martinique, Caribbean, insular region of France NCMA PHYC 109,080 [89]
Mixed PR Puerto Rico, United States of America CCFHR CCFHR 98,560 [75]
St Maartens Gam10 St. Maarteens, Kingdom of the Netherlands CCFHR CCFHR 116,000 [75]
SW Algae Gam1 Southwater Cay, Belize CCFHR CCFHR 76,410 [75]
G. scabrosus KW070922_1 Kashiwa-jima Island, Otsuki, Kochi, Japan KU PHYC 771,711 [63,87]
G. silvae
UNR-30 Brazil UNIRIO UNIRIO 362,877 Unpublishedstrain
VGO1167 Punta Hidalgo, Tenerife, Canary Islands, Spain CCVIEO PHYC 502,080 [62]
VGO1180 Punta Hidalgo, Tenerife, Canary Islands, Spain CCVIEO PHYC 421,430 [62]
Gambierdiscus sp. Viet Nam Cau Island, Binh Thuan, South China Sea, Viet Nam VNIO PHYC 1,726,949 [67,83,90]
G. toxicus
GTT-91 Teahupoo, Tahiti, French Polynesia CCFHR CCFHR 116,625 [70]
HIT-0 Hitiaa, Tahiti, French Polynesia CCFHR CCFHR 106,650 [70]
HIT-25 Hitiaa, Tahiti, French Polynesia CCFHR CCFHR 74,800 [70]
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4.4. Fractionation of Gambierdiscus excentricus VGO791 and VGO792
After three weeks of semi-continuous culture [69], cells were first filtered on a 25 µm sieve, then
harvested by centrifugation (20 min, 3000 g, 4 ◦C) in 50 mL Falcon® tubes. A total of 2.20 million cells
(3.307 g wet pellet, 4.5 L of culture, 15 flasks) and 2.16 million cells (3.076 g wet pellet, 4.5 L of culture,
15 flasks) were harvested for G. excentricus VGO791 and VGO792, respectively. Cell pellets were stored
at −20 ◦C until further extraction for toxicity screening and chemical analyses. After the cells had been
harvested in log phase growth, they were extracted as described above (Section 4.3). An aliquot of crude
extract volume was filtered through a Nanosep MF 0.2 µm filter and stored at −20 ◦C until cellular
bioassays and LC-MS analyses. The remnant part was evaporated under N2 at 40 ◦C and stored at−20 ◦C.
4.4.1. Liquid-Liquid Partitioning
The residues of crude extracts (0.263 g for G. excentricus VGO791 and 0.251 g for G. excentricus
VGO792) were suspended in dichloromethane (50 mL per 1 million cells) and partitioned twice
with MeOH:H2O (3:2, v/v) (25 mL per 1 million cells) as previously described by Satake, et al. [91].
Maitotoxins are supposed to partition into the aqueous methanol soluble fraction (MSF). Once the MSF
was isolated, it was blown dry under N2 gas at 40 ◦C and stored at −20 ◦C. The dried MSF residue
was re-dissolved in 1.5 mL MeOH:H2O (1:1, v/v) and filtered through a Nanosep MF 0.2 µm filter.
4.4.2. Size-Exclusion Chromatography (SEC): Sephadex™ LH-20
Prior to use, Sephadex™ LH-20 powder (10 g) was swollen in methanol (MeOH) over one night,
then gently packed in a glass open column (intern diameter: 1 cm) in one continuous motion and finally
rinsed with MeOH. Bed height was 52.7 cm, hence bed volume was calculated to be 41.4 mL. An aliquot
of MSFs of G. excentricus VGO791 (0.745 mL, 1.082 million cells, 32.5 mg MSF residue) and G. excentricus
VGO792 (0.700 mL, 0.998 million cells, 29.9 mg MSF residue) were separately deposited on the top of
the LH-20 column; compounds were then eluted with MeOH under atmospheric pressure (flow rate:
0.4 mL min−1). Eluting fractions were collected as follows: 50 fractions of 2.5 mL each for G. excentricus
VGO791; 1st fraction of 10 mL, 45 fractions of 1 mL and two last fractions of 30 mL for G. excentricus
VGO792. All the fractions were screened for toxicity (N2a assays), and analyzed by LC-MS at either high
or low resolutions, in either HRMS full scan or targeted HRMS/MS and LRMS/MS modes.
4.5. Neuroblastoma Neuro-2a (N2a) Assays
4.5.1. N2a Cytotoxicity Assay
The N2a cytotoxicity assay was performed at the Phycotoxins Laboratory (Ifremer, Nantes, France)
using the protocol for MTX detection described by Caillaud, et al. [92].
The N2a cell line was obtained from the American Type Culture Collection (ATCC, CCL 131). N2a
cells were grown and maintained as described by Hardison, et al. [93]. The assay was carried out in
96-well flat-bottom Falcon® tissue culture plates with vacuum gas plasma treatment for cell adhesion
(Dominique DUTSCHER SAS, Brumath, France). Plates were seeded with 30,000 N2a cells per well and
were incubated for 24 h until they were >90% confluent at the bottom of each well. The MTX standard,
controls and G. excentricus samples were added next and incubated for 2.5 h. The 6-point MTX standard
curve for this assay ranged from 0.29 to 29,127 ng mL−1 per well. Controls included buffer wells to
provide maximum survival estimates and wells with the addition of 3% MeOH (final concentration
in well) to identify any cell mortality caused by the presence of MeOH used to dissolve the samples.
The following sample aliquots (3 µL additions) were tested: MSF extracts of G. excentricus VGO791 and
VGO792 and their respective fractions obtained by SEC (LH-20). Total well volume was hence 103 µL.
For each sample, six 10-fold serial dilutions were tested in three separate experiments and three
replicate wells for each dilution were run for each experiment. Sigmoidal dose-response curves were
plotted using the four-parameter logistic model (4PL) and EC50 values (cell eq mL−1) were calculated
for each sample using SigmaPlot® 12. Quantitation of MTX eq in the samples using the N2a cytotoxicity
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assay was calculated by converting EC50 values (cell eq mL−1) into toxin equivalent per cell (pg MTX
eq cell−1) taking into account the EC50 value obtained from the MTX standard curve. Results were
then converted in µg MTX eq multiplying for the initial number of cells extracted.
Cell viability was assessed after 2.5 h incubation using the quantitative colorimetric
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay [94] using a Tecan Infinite®
M200 plate reader (Tecan Austria GmbH, Grödig, Austria) at 544 nm. The viability of cells treated with
MTX standard or algal extracts was estimated relative to control wells in solvent vehicle (3% MeOH in
N2a medium).
4.5.2. N2a Calcium Flux Assay
The high-content screening (HCS) assay employed an automated epifluorescence microscopy and
image analysis of cells in a microtiter plate format [95,96]. In the present study, HCS assay was used
to measure Ca2+ influx induced by MTXs using the N2a cell line. The assay was performed at the
Toxicology of Contaminants Unit, ANSES Laboratory (Fougères, France).
N2a cells (ATCC, CCL 131) were grown and maintained as described by Sérandour et al. [97].
The assay was carried out in Nunc 96-well thin bottom microplates (Thermo Scientific, Waltham, MA,
USA). Each well was seeded with 33,000 N2a cells and plates were incubated for 24 h until they were
>90% confluent at the bottom of each well. Next, two fluorescent dyes, Hoechst 33342 (3 µg mL−1) for
cell nuclei staining and Fluo-4-AM (5 µM) for iCa2+ staining, were added to each well and the plates
were placed back in the incubator for 40 min.
Vehicle control solution for the assay consisted of N2a culture medium without fetal calf
serum (FCS) containing 5% MeOH. The MTX standard curve for the assay ranged from 26.7 to
102,776 pg mL−1 in well (from 7.81 to 30,000 pM) and was prepared in FCS-free N2a culture medium
containing 5% MeOH. The crude extract and partially purified extracts from G. excentricus VGO791
were prepared as follows: 0.05 mL of each sample were diluted in 0.95 mL of FCS-free N2a culture
medium resulting in a solution with final MeOH content of 5%.
Six wells per plate were dedicated to vehicle control exposure to identify any non-specific flux of
Ca2+ due to the presence of 5% MeOH. For each sample, three separate experiments were performed,
and each experiment was run in three replicate wells. N2a medium was discarded from the wells,
one-by-one, and immediately replaced with 100 µL of vehicle control, MTX standard or G. excentricus
VGO791 samples just before the fluorescence measurement. Fluorescence (388 nm for cell nuclei,
488 nm for iCa2+) was followed in real-time with one image per 1.5 min frame rate using an ArrayScan
VTI HCS Reader (Thermo Scientific, Waltham, MA, USA) with 10× objective. Intracellular calcium
signal was assessed after 4.5 min exposure and expressed as a fold of intensity compared to control
treatment (5% MeOH in FCS-free N2a culture medium).
4.6. LC-MS Analyses
4.6.1. LC-HRMS and HRMS/MS (Q-Tof 6550 iFunnel)
LC-HRMS analyses were performed at the Phycotoxins Laboratory (Ifremer, Nantes, France)
using a UHPLC system 1290 Infinity II (Agilent Technologies, Santa Clara, CA, USA) coupled to a
high resolution time-of-flight mass spectrometer Q-Tof 6550 iFunnel (Agilent Technologies, Santa
Clara, CA, USA) equipped with a Dual Jet Stream® electrospray ionization (ESI) interface operating
in negative mode. Toxins were separated using a reversed-phase C18 Kinetex column (100 Å, 2.6 µm,
50 × 2.1 mm, Phenomenex, Le Pecq, France) with water (A) and 95% acetonitrile/water (B). The
column oven and the sample tray temperatures were set at 40 ◦C and 4 ◦C, respectively. The flow
rate was set at 0.4 mL min−1, the injection volume was set at 3 µL. Separation was achieved using
the following mobile phase gradient: from 10 to 95% B in 10 min, plateau at 95% B for 2 min, return
to the initial condition (10% B) in 0.1 min and a re-equilibration period (10% B) for 3.9 min. The
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chromatographic run lasted 16 min per analysis. The MTX standard used for LC-HRMS experiments
was at a concentration of 20 µg mL−1 MeOH:H2O (1:1, v/v).
The conditions of the ESI source were set as follows: source temperature, 200 ◦C; drying gas, N2;
flow rate, 11 mL min−1; sheath gas temperature, 350 ◦C; sheath gas flow rate, 11 mL min−1; nebulizer,
45 psig; capillary voltage, −3.5 kV; nozzle voltage, 500 V. The instrument was mass calibrated in
negative ionization mode before each analysis, using the Agilent tuning mix. A mixture solution of
reference mass compounds (purine, 2 mL L−1; HP-0921, 1 mL L−1; HP-1221, 1 mL L−1; HP-1821,
2 mL L−1; HP-2421, 2 mL L−1) in MeOH:H2O (95:5, v/v) was infused with an isocratic pump to a
separate ESI sprayer in the dual spray source at a constant flow rate of 1.5 µL min−1. Purine and
HP-0921 allowed for correction of the measured m/z throughout the batch.
Mass spectrum detection was carried out in full scan and targeted MS/MS mode in negative
ion acquisition. The full scan acquisition operated at a mass resolution of 45,000 Full Width at Half
Maximum (FWHM) over a mass-to-charge ratio (m/z) range from 100 to 3200 with a scan rate of
2 spectra s−1. The LOD (S/N ratio > 3) calculated for MTX (negative mode EIC of 1688.8013 m/z) was
1.88 µg mL−1. The targeted MS/MS mode was performed in a Collision Induced Dissociation cell
using a mass resolving power of 45,000 FWHM over the scan range m/z from 50 to 3200 with a MS
scan rate of 10 spectra s−1 and a MS/MS scan rate of 3 spectra s−1. Three different collision energies
were applied to the precursor ions to obtain a good fragmentation pathway.
All the acquisition and analysis data were controlled by MassHunter software (Agilent
Technologies, Santa Clara, CA, USA). Raw data were processed using the Molecular Feature Extraction
(MFE) algorithm of the Agilent MassHunter Qualitative Analysis software, version B.07.00, service
pack 1 (Agilent Technologies, Santa Clara, CA, USA). The algorithm performs all tasks related
to “peak-picking” and thus allowed for identification of all sample components down to the
lowest-level abundance (abundance cut-off set at 500 counts) and to extract all relevant spectral
and chromatographic information. Data-mining was carried out to manage data complexity and to
correlate MS data to toxicity.
4.6.2. LC-LRMS/MS (API 4000 QTrap)
LC-LRMS/MS experiments to monitor specific MTX congeners in the methanolic extracts
obtained from the strains listed in Table 5 were performed at the Phycotoxins Laboratory (Ifremer,
Nantes, France) using a LC system (UFLC XR Nexera, Shimadzu, Japan) coupled to a hybrid triple
quadrupole/ion-trap mass spectrometer API 4000 QTrap (SCIEX, Redwood City, CA, USA) equipped
with a turboV® ESI source. Toxins were separated using the same chromatographic conditions as
described above (Section 4.6.1). The injection volume was set at 5 µL. Mass spectrum detection was
carried out in negative ion acquisition mode using multiple reactions monitoring (MRM).
The MTX standard calibration range for the LC-LRMS/MS experiments consisted of nine
concentrations ranging from 0.1 to 20 µg mL−1 MeOH:H2O (1:1, v/v). MRM experiments were
established using the following source settings: curtain gas set at 25 psi, ion spray at−4.5 kV, a turbogas
temperature of 300 ◦C, gas 1 and 2 set, respectively, at 40 and 60 psi, an entrance and declustering
potential of−10 V and−210 V, respectively. The limit of detection (LOD) and the limit of quantification
(LOQ) were determined with the ordinary least-squares regression data method [98,99] using the
lowest 3 points from the calibration curves. The LOD was calculated as 3 times the standard deviation
of the y-intercepts over the slope of the calibration curve; the LOQ was calculated as 10 times the
standard deviation of the y-intercepts over the slope of the calibration curve [98,99].
The fragment ion monitored for all the MRM transition of the MTX-group of toxins was the
hydrogenated sulfate anion [HOSO3]− (m/z 96.9). The precursor ions were chosen according to data
available in literature or provided in this study. Seven and six MRM transitions (m/z), were monitored
for MTX and MTX4, respectively, to permit the best toxin identification (Table 6) with a dwell time of
80 msec. Quantification of MTX and MTX4 was operated using the MRM transition [M − 2H]2− →
[M − 2H]2−. MTX4 was quantified over the MTX calibration curve, assuming equal molar response
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and applying the same LOD and LOQ calculated for MTX. In the absence of MS/MS data on MTX2,
precursor ions (m/z) were selected according to Lewis et al. [56]. Bi-charged and tri-charged molecular
anions were also calculated and added to the MRM method (Table 6). For MTX3, the lack of MS data in
negative ion acquisition mode did not allow the selection of precursor ions (m/z) which were already
described in literature. In the present study, a MRM transition involving [M + Na − 2H]− as precursor
ion was selected according to a previous study conducted by Kohli et al. [72]. MRM transitions in
this study also involved the corresponding molecular mono-charged anion [M − H]− (calculated m/z
1015.5), its di-sodium adduct (calculated m/z 1057.5) and the molecular bi-charged anion [M − 2H]2−
(calculated m/z 507.3) as precursor ions (Table 6).
Table 6. List of the MRM transitions (m/z) for the four MTXs known to date (LC-LRMS/MS, API 4000
QTrap). MRM transitions of MTX and MTX4 were chosen according to HRMS data provided in this
study. Quantification of MTX and MTX4 was operated using the MRM transition [M − 2H]2− → [M
− 2H]2− (in bold). In the absence of MS/MS data on maitotoxin-2 (MTX2) and maitotoxin-3 (MTX3),
putative MRM transitions were chosen based on their MS spectral peaks reported in literature and
assuming that they share the same fragmentation behavior as that of MTX and MTX4. * = M refers to
the free acid form, i.e., without the sodium salt(s) on sulfate ester group(s), e.g., M = C164H258O68S2
for MTX.
Compound MRM Transitions (m/z) * CE (eV) CXP (eV)
MTX
[M− 2H]2−/[M− 2H]2− 1689.8/1689.8 −40 −15
[M − 2H]2−/[HOSO3]− 1689.8/96.9 −125 −21
[M + Na − 3H]2−/[HOSO3]− 1700.8/96.9 −125 −21
[M + 2Na − 3H]2−/[HOSO3]− 1711.8/96.9 −125 −21
[M − 3H]3−/[M − 3H]3− 1126.2/1126.2 −40 −15
[M − 3H]3−/[HOSO3]− 1126.2/96.9 −125 −21
[M − 4H]4−/[HOSO3]− 844.4/96.9 −125 −21
MTX2
[M − 2H]2−/[HOSO3]− 1637.5/96.9 −125 −21
[M + Na − 3H]2−/[HOSO3]− 1648.2/96.9 −125 −21
[M + K − 3H]2−/[HOSO3]− 1656.0/96.9 −125 −21
[M − 3H]3−/[HOSO3]− 1091.5/96.9 −125 −21
[M + Na − 4H]3−/[HOSO3]− 1098.6/96.9 −125 −21
[M + K − 4H]3−/[HOSO3]− 1103.8/96.9 −125 −21
MTX3
[M − H]−/[HOSO3]− 1015.5/96.9 −125 −21
[M + Na − 2H]−/[HOSO3]− 1037.6/96.9 −125 −21
[M + 2Na − 3H]−/[HOSO3]− 1057.5/96.9 −125 −21
[M − 2H]2−/[HOSO3]− 507.3/96.9 −125 −21
MTX4
[M− 2H]2−/[M− 2H]2− 1646.2/1646.2 −40 −15
[M − 2H]2−/[HOSO3]− 1646.2/96.9 −125 −21
[M + Na − 3H]2−/[HOSO3]− 1657.2/96.9 −125 −21
[M + 2Na − 3H]2−/[HOSO3]− 1668.2/96.9 −125 −21
[M − 3H]3−/[M − 3H]3− 1097.1/1097.1 −40 −15
[M − 3H]3−/[HOSO3]− 1097.1/96.9 −125 −21
Supplementary Materials: The following are available online at www.mdpi.com/1660-3397/15/7/220/s1,
Figure S1. Sigmoidal dose-response curve of MTX standard on the neuroblastoma N2a cytotoxicity assay after 2.5
h exposure. Error bars represent assay variability (standard deviation, SD) measured by running extracts in three
separate assays. In each assay, three separate wells were used for assaying each fraction. Figure S2. Sigmoidal
dose-response curve of MTX standard on the N2a-based HCS assay for Ca2+ flux after 4.5 min exposure. Ca2+
flux was estimated measuring the fluorescence of the Fluo-4-AM dye at 488 nm. Fluo-4-AM fluorescence was
expressed as a fold of intensity compared to vehicle control condition (5% MeOH in FCS-free N2a medium). Error
bars represent assay variability (standard deviation, SD) measured by running extracts in three separate assays.
In each assay, three separate wells were used for assaying each fraction.
Acknowledgments: The authors acknowledge Ifremer and the Regional Council of the Région des Pays de la
Loire for Ph.D. funding of F. Pisapia. S. Fraga thanks MINECO for funding project CICAN. The authors would
Mar. Drugs 2017, 15, 220 26 of 31
like to thank Luiz Mafra Jr. for establishing contacts between several of the authors and the International Atomic
Energy Agency (IAEA) for funding through the Core Research Project CRP-K41014. The authors gratefully
acknowledge Masao Adachi and Tomohiro Nishimura for the provision of the two Gambierdiscus strains
G. scabrosus (KW070922_1) and G. australes (S080911_1).
Author Contributions: F.P., M.S., C.H. and P.H. conceived and designed the experiments; F.P. and G.G. performed:
cultures of Gambierdiscus, cell pellet extraction, size-exclusion chromatography and cytotoxicity screening via N2a
cytotoxicity assay; F.P. and K.L. performed the cultures of N2a cells; F.P., V.F. and P.-J.F. designed and performed
the N2a Ca2+ flux high-content screening (HCS) assay experiments; F.P., M.S., P.H. and C.H. performed and
analyzed the HRMS/MS and LRMS/MS data; S.F., S.M.N. and W.C.H. contributed some of the strains and culture
material used in this study, V.F., C.R. contributed reagents, materials and data analysis; F.P. wrote the paper; V.F.,
C.R., R.W.L., C.H. and P.H. corrected and revised the paper.
Conflicts of Interest: The authors declare no conflict of interest. The funding sponsors had no role in the design
of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the
decision to publish the results.
References
1. Murata, M.; Naoki, H.; Iwashita, T.; Matsunaga, S.; Sasaki, M.; Yokoyama, A.; Yasumoto, T. Structure of
maitotoxin. J. Am. Chem. Soc. 1993, 115, 2060–2062. [CrossRef]
2. Kelley, B.A.; Jollow, D.J.; Felton, E.T.; Voegtline, M.S.; Higerd, T.B. Response of mice to Gambierdiscus toxicus
toxin. Mar. Fish. Rev. 1986, 48, 35–37.
3. Kohli, G.S.; Papiol, G.G.; Rhodes, L.L.; Harwood, D.T.; Selwood, A.; Jerrett, A.; Murray, S.A.; Neilan, B.A. A
feeding study to probe the uptake of maitotoxin by snapper (Pagrus auratus). Harmful Algae 2014, 37, 125–132.
[CrossRef]
4. Yasumoto, T.; Bagnis, R.; Vernoux, J. Toxicity of the surgeonfishes II. Properties of the principal water-soluble
toxin. Bull. Jpn. Soc. Sci. Fish 1976, 42, 359–365. [CrossRef]
5. Yasumoto, T.; Hashimoto, Y.; Bagnis, R.; Randall, J.E.; Banner, A.H. Toxicity of the surgeonfishes.
Nippon Suisan Gakkaishi 1971, 37, 724–734. [CrossRef]
6. Yasumoto, T.; Seino, N.; Murakami, Y.; Murata, M. Toxins produced by benthic dinoflagellates. Biol. Bull.
1987, 172, 128–131. [CrossRef]
7. Murata, M.; Naoki, H.; Matsunaga, S.; Satake, M.; Yasumoto, T. Structure and partial stereochemical
assignments for maitotoxin, the most toxic and largest natural non-biopolymer. J. Am. Chem. Soc. 1994, 116,
7098–7107. [CrossRef]
8. Murata, M.; Yasumoto, T. The structure elucidation and biological activities of high molecular weight algal
toxins: Maitotoxin, prymnesins and zooxanthellatoxins. Nat. Prod. Rep. 2000, 17, 293–314. [CrossRef]
[PubMed]
9. Yokoyama, A.; Murata, M.; Oshima, Y.; Iwashita, T.; Yasumoto, T. Some chemical properties of maitotoxin,
a putative calcium channel agonist isolated from a marine dinoflagellate. J. Biochem. 1988, 104, 184–187.
[CrossRef] [PubMed]
10. Gusovsky, F.; Daly, J.W. Maitotoxin: A unique pharmacological tool for research on calcium-dependent
mechanisms. Biochem. Pharmacol. 1990, 39, 1633–1639. [CrossRef]
11. Reyes, J.G.; Sánchez-Cárdenas, C.; Acevedo-Castillo, W.; Leyton, P.; López-González, I.; Felix, R.;
Gandini, M.A.; Treviño, M.B.; Treviño, C.L. Maitotoxin: An enigmatic toxic molecule with useful applications
in the biomedical sciences. In Seafood and Freshwater Toxins: Pharmacology, Physiology and Detection;
Botana, L.M., Ed.; CRC Press (Taylor & Francis Group): Boca Raton, FL, USA, 2014; pp. 677–694.
12. Ogura, A.; Ohizumi, Y.; Yasumoto, T. Calcium-dependent depolarization induced by a marine toxin,
maitotoxin, in a neuronal cell. Jpn. J. Pharmacol. 1984, 36, P315.
13. Gusovsky, F.; Bitran, J.A.; Yasumoto, T.; Daly, J.W. Mechanism of maitotoxin-stimulated phosphoinositide
breakdown in HL-60 cells. J. Pharmacol. Exp. Ther. 1990, 252, 466–473. [PubMed]
14. Ohizumi, Y.; Yasumoto, T. Contraction and increase in tissue calcium content induced by maitotoxin, the
most potent known marine toxin, in intestinal smooth muscle. Br. J. Pharmacol. 1983, 79, 3–5. [CrossRef]
[PubMed]
15. Ohizumi, Y.; Yasumoto, T. Contractile response of the rabbit aorta to maitotoxin, the most potent marine
toxin. J. Physiol. Lond. 1983, 337, 711–721. [CrossRef] [PubMed]
Mar. Drugs 2017, 15, 220 27 of 31
16. Ohizumi, Y.; Kajiwara, A.; Yasumoto, T. Excitatory effect of the most potent marine toxin, maitotoxin, on the
guinea-pig vas deferens. J. Pharmacol. Exp. Ther. 1983, 227, 199–204. [PubMed]
17. Treviño, C.L.; De la Vega-Beltrán, J.L.; Nishigaki, T.; Felix, R.; Darszon, A. Maitotoxin potently promotes
Ca2+ influx in mouse spermatogenic cells and sperm, and induces the acrosome reaction. J. Cell. Physiol.
2006, 206, 449–456. [CrossRef] [PubMed]
18. Nishiyama, I.; Matsui, T.; Yasumoto, T.; Oshio, S.; Hoshi, M. Maitotoxin, a presumed calcium-channel
activator, induces the acrosome reaction in mussel spermatozoa. Dev. Growth Differ. 1986, 28, 443–448.
[CrossRef]
19. Amano, T.; Okita, Y.; Yasumoto, T.; Hoshi, M. Maitotoxin induces acrosome reaction and histone degradation
of starfish Asterina pectinifera sperm. Zool. Sci. 1993, 10, 307–312.
20. Taglialatela, M.; Amoroso, S.; Yasumoto, T.; Di Renzo, G.; Annunziato, L. Maitotoxin and Bay-K-8644:
Two putative calcium channel activators with different effects on endogenous dopamine release from
tuberoinfundibular neurons. Brain Res. 1986, 381, 356–358. [CrossRef]
21. Ohizumi, Y.; Kajiwara, A.; Yasumoto, T. Mode of the noradrenaline release induced by maitotoxin, the
principal toxin of poisonous fishes inhabiting tropical seas, from adrenergic nerves. Folia Pharmacol. Jpn.
1983, 82, 158.
22. Takahashi, M.; Tatsumi, M.; Ohizumi, Y.; Yasumoto, T. Ca2+ channel activating function of maitotoxin, the
most potent marine toxin known, in clonal rat pheochromocytoma cells. J. Biol. Chem. 1983, 258, 944–949.
23. Pin, J.-P.; Yasumoto, T.; Bockaert, J. Maitotoxin-evoked
Mar. Drugs 2017, 15, 220 27 of 31 
 
17. Treviño, C.L.; De la Vega-Beltrán, J.L.; Nishigaki, T.; Felix, R.; Darszon, A. Maitotoxin potently promotes 
Ca2+ influx in mouse spermatogenic cells and sperm, and induces the acrosome action. J. Cell. Physiol. 
2006, 206, 449–456. 
18. Nishiyama, I.; Matsui, T.; Yasumoto, T.; Oshio, S.; Hoshi, M. Maitotoxin, a presumed calcium-channel 
activator, induces the acrosome reaction in mussel spermatozoa. Dev. Growth Differ. 1986, 28, 443–448. 
19. Amano, T.; Okita, Y.; Yasumoto, T.; Hoshi, M. Maitotoxin induces acrosome reaction and histone 
degradation of starfish Asterina pectinifera sperm. Zool. Sci. 1993, 10, 307–312. 
20. Taglialatela, M.; Amoroso, S.; Yasumoto, T.; Di Renzo, G.; Annunziato, L. Maitotoxin and Bay-K-8644: 
Two putative calcium channel activators with different effects on endogenous dopamine release from 
tuberoinfundibular neurons. Brain Res. 1986, 381, 356–358. 
21. Ohizumi, Y.; Kajiwara, A.; Yasumoto, T. Mode of the noradrenaline release induced by maitotoxin, the 
principal toxin of poisonous fishes inhabiting tropical seas, fro  adrenergic nerves. Folia Pharmacol. Jpn. 
1983, 82, 158. 
22. T kahashi, M.; Tatsumi, M.; Ohizumi, Y.; Yasumoto, T. Ca2+ channel activating function f maitotoxin, the 
m st potent marine toxi  known, in clonal rat pheochr to a cells. J. Biol. Chem. 1983, 258, 944–9 9. 
23. Pin, J.-P.; Yasumoto, T.; Bockaert, J. Maitotoxin-evoked ɣ-aminobutyric acid release is due not only to the 
opening of calcium channels. J. Neurochem. 1988, 50, 1227–1232. 
24. Leech, C.A.; Habener, J.F. Insulinotropic glucagon-like peptide-1-mediated activation of non-selective 
cation currents in insulinoma cells is mimicked by maitotoxin. J. Biol. Chem. 1997, 272, 17987–17993. 
25. Soergel, D.G.; Gusovsky, F.; Yasumoto, T.; Daly, J.W. Stimulatory effects of maitotoxin on insulin release 
in insulinoma HIT cells: Role of calcium uptake and phosphoinositide breakdown. J. Pharmacol. Exp. Ther. 
1990, 255, 1360–1365. 
26. Choi, O.H.; Padgett, W.L.; Nishizawa, Y.; Gusovsky, F.; Yasumoto, T.; Daly, J.W. Maitotoxin: Effects on 
calcium channels, phosphoinositide breakdown, and arachidonate release in pheochromocytoma PC12 
cells. Mol. Pharmacol. 1990, 37, 222–230. 
27. Columbo, M.; Taglialatela, M.; Warner, J.A.; Macglashan, D.W.; Yasumoto, T.; Annunziato, L.; Marone, G. 
Maitotoxin, a novel activator of mediator release from human basophils, induces large increase in 
cytosolic calcium resulting in histamine, but not leukotriene-Crelease. J. Pharmacol. Exp. Ther. 1992, 263, 
979–986. 
28. Estacion, M.; Schilling, W.P. Maitotoxin-induced membrane blebbing and cell death in aortic endothelial 
cells. FASEB J. 2001, 1, 2. 
29. Schilling, W.P.; Sinkins, W.G.; Estacion, M. Maitotoxin activates a nonselective cation channel and a 
P2Z/P2X(7)-like cytolytic pore in human skin fibroblasts. Am. J. Physiol. Cell Physiol. 1999, 277, C755–C765. 
30. Schilling, W.P.; Wasylyna, T.; Dubyak, G.R.; Humphreys, B.D.; Sinkins, W.G. Maitotoxin and P2Z/P2X(7) 
purinergic receptor stimulation activate a common cytolytic pore. Am. J. Physiol. Cell Physiol. 1999, 277, 
C766–C766. 
31. Sasaki, M.; Matsumori, N.; Maruyama, T.; Nonomura, T.; Murata, M.; Tachibana, K.; Yasumoto, T. The 
complete structure of maitotoxin, part I: Configuration of the C1-C14 side chain. Angew. Chem. Int. Ed. Engl. 
1996, 35, 1672–1675. 
32. Nonomura, T.; Sasaki, M.; Matsumori, N.; Murata, M.; Tachibana, K.; Yasumoto, T. The complete structure 
of maitotoxin, part II: Configuration of the C135-C142 side chain and absolute configuration of the entire 
molecule. Angew. Chem. Int. Ed. Engl. 1996, 35, 1675–1678. 
33. Zheng, W.J.; DeMattei, J.A.; Wu, J.P.; Duan, J.J.W.; Cook, L.R.; Oinuma, H.; Kishi, Y. Complete relative 
stereochemistry of maitotoxin. J. Am. Chem. Soc. 1996, 118, 7946–7968. 
34. Gallimore, A.R.; Spencer, J.B. Stereochemical uniformity in marine polyether ladders—Implications for the 
biosynthesis and structure of maitotoxin. Angew. Chem. Int. Ed. Engl. 2006, 45, 4406–4413. 
35. Nicolaou, K.C.; Frederick, M.O. On the structure of maitotoxin. Angew. Chem. Int. Ed. 2007, 46, 5278–5282. 
36. Nicolaou, K.C.; Cole, K.P.; Frederick, M.O.; Aversa, R.J.; Denton, R.M. Chemical synthesis of the GHIJK 
ring system and further experimental support for the originally assigned structure of maitotoxin. Angew. 
Chem. Int. Ed. 2007, 46, 8875–8879. 
37. Takahashi, M.; Ohizumi, Y.; Yasumoto, T. Maitotoxin, a Ca2+ channel activator candidate. J. Biolog. Chem. 
1982, 257, 7287–7289. 
38. Freedman, S.B.; Miller, R.J.; Miller, D.M.; Tindall, D.R. Interactions of maitotoxin with voltage-sensitive 
calcium channels in cultured neuronal cells. Proc. Natl. Acad. Sci. USA 1984, 81, 4582–4585. 
-a inobutyric acid release is due not only to the
opening of calcium channels. J. Neurochem. 1988, 50, 1227–1232. [CrossRef] [PubMed]
24. Leech, C.A.; Habener, J.F. Insulinotropic glucagon-like peptide-1-mediated activation of non-selective cation
currents in insulinoma cells is mimicked by maitotoxin. J. Biol. Chem. 1997, 272, 17987–17993. [CrossRef]
[PubMed]
25. Soergel, D.G.; Gusovsky, F.; Yasumoto, T.; Daly, J.W. Stimulatory effects of maitotoxin on insulin release in
insulinoma HIT cells: Role of calcium uptake and phosphoinositide breakdown. J. Pharmacol. Exp. Ther.
1990, 255, 1360–1365. [PubMed]
26. Choi, O.H.; Padgett, W.L.; Nishizawa, Y.; Gusovsky, F.; Yasumoto, T.; Daly, J.W. Maitotoxin: Effects on
calcium channels, phosphoinositide breakdown, and ar chidonate release in pheochromocytoma PC12 cells.
Mol. Pharmacol. 1990, 37, 222–230. [PubMed]
27. Columbo, M.; Taglialatela, M.; Warner, J.A.; Macglashan, D.W.; Yasumoto, T.; Annunziato, L.; Marone, G.
Maitotoxin, a novel activator of mediator release from human basophils, induces large increase in cytosolic
calcium resulting in histamine, but not leukotriene-Crelease. J. Pharmacol. Exp. Ther. 1992, 263, 979–986.
[PubMed]
28. Estacion, M.; Schilling, W.P. Maitotoxin-induced membrane blebbing and cell death in aortic endothelial
cells. FASEB J. 2001, 1, 2.
29. Schilling, W.P.; Sinkins, W.G.; Estacion, M. Maitotoxin activates a nonselective cation channel and a
P2Z/P2X(7)-like cytolytic pore in human skin fibroblasts. Am. J. Physiol. Cell Physiol. 1999, 277, C755–C765.
30. Schilling, W.P.; W sylyna, T.; Dubyak, G.R.; Humphreys, B.D.; Sinkins, W.G. Maitotoxin and P2Z/P2X(7)
purinergic r ceptor stimul ti n activa e a common cytolytic pore. Am. J. Physiol. ell Physiol. 1999, 277,
C766–C776.
31. Sasaki, M.; Matsumori, N.; aruyama, T.; Nonomura, T.; Murata, M.; Tachibana, K.; Yasumoto, T. The
complete structure of maitotoxin, part I: Configuration of the C1-C14 side chain. Angew. Chem. Int. Ed. Engl.
1996, 35, 1672–1675. [CrossRef]
32. Nonomura, T.; Sasaki, M.; Matsumori, N.; Murata, M.; Tachibana, K.; Yasumoto, T. The complete structure
of maitotoxin, part II: Configuration of the C135-C142 side chain and absolute configuration of the entire
molecule. Angew. Chem. Int. Ed. Engl. 1996, 35, 1675–1678. [CrossRef]
33. Zheng, W.J.; DeMattei, J.A.; Wu, J.P.; Duan, J.J.W.; Cook, L.R.; Oinuma, H.; Kishi, Y. Complete relative
stereochemistry of maitotoxin. J. Am. Chem. Soc. 1996, 118, 7946–7968. [ rossRef]
34. Gallimore, A.R.; Spencer, J.B. Stereochemical uniformity in marine polyether ladders—Implicatio s for the
biosynthesis an structure of maitotoxin. Angew. Chem. Int. Ed. Engl. 2006, 45, 4406–4413. [CrossRef]
[PubMed]
35. Nicolaou, K.C.; Frederick, M.O. On the structure of maitotoxin. Angew. Chem. Int. Ed. 2007, 46, 5278–5282.
[CrossRef] [PubMed]
Mar. Drugs 2017, 15, 220 28 of 31
36. Nicolaou, K.C.; Cole, K.P.; Frederick, M.O.; Aversa, R.J.; Denton, R.M. Chemical synthesis of the GHIJK ring
system and further experimental support for the originally assigned structure of maitotoxin. Angew. Chem.
Int. Ed. 2007, 46, 8875–8879. [CrossRef] [PubMed]
37. Takahashi, M.; Ohizumi, Y.; Yasumoto, T. Maitotoxin, a Ca2+ channel activator candidate. J. Biolog. Chem.
1982, 257, 7287–7289.
38. Freedman, S.B.; Miller, R.J.; Miller, D.M.; Tindall, D.R. Interactions of maitotoxin with voltage-sensitive
calcium channels in cultured neuronal cells. Proc. Natl. Acad. Sci. USA 1984, 81, 4582–4585. [CrossRef]
[PubMed]
39. Cataldi, M.; Secondo, A.; D’Alessio, A.; Taglialatela, M.; Hofmann, F.; Klugbauer, N.; Di Renzo, G.;
Annunziato, L. Studies on maitotoxin-induced intracellular Ca2+ elevation in Chinese hamster ovary cells
stably transfected with cDNAs encoding for L-type Ca2+ channel subunits. J. Pharmacol. Exp. Ther. 1999, 290,
725–730. [PubMed]
40. Brereton, H.M.; Chen, J.L.; Rychkov, G.; Harland, M.L.; Barritt, G.J. Maitotoxin activates an endogenous
non-selective cation channel and is an effective initiator of the activation of the heterologously expressed
hTRPC-1 (transient receptor potential) non-selective cation channel in H4-IIE liver cells. Biochim. Biophys.
Acta Mol. Cell Res. 2001, 1540, 107–126. [CrossRef]
41. Morales-Tlalpan, V.; Vaca, L. Modulation of the maitotoxin response by intracellular and extracellular cations.
Toxicon 2002, 40, 493–500. [CrossRef]
42. Gutierrez, D.; Diaz de Leon, L.; Vaca, L. Characterization of the maitotoxin-induced calcium influx pathway
from human skin fibroblasts. Cell Calcium 1997, 22, 31–38. [CrossRef]
43. Martinez-Francois, J.R.; Morales-Tlalpan, V.; Vaca, L. Characterization of the maitotoxin-activated cationic
current from human skin fibroblasts. J. Physiol. Lond. 2002, 538, 79–86. [CrossRef] [PubMed]
44. Meunier, F.A.; Mattei, C.; Molgo, J. Marine toxins potently affecting neurotransmitter release. Prog. Mol.
Subcell. Biol. 2009, 46, 159–186. [PubMed]
45. Frew, R.; Wang, Y.S.; Weiss, T.M.; Nelson, P.; Sawyer, T.W. Attenuation of maitotoxin-induced cytotoxicity in
rat aortic smooth muscle cells by inhibitors of Na+/Ca2+ exchange, and calpain activation. Toxicon 2008, 51,
1400–1408. [CrossRef] [PubMed]
46. Wang, Y.S.; Weiss, M.T.; Yin, J.F.; Frew, R.; Tenn, C.; Nelson, P.P.; Vair, C.; Sawyer, T.W. Role of the sodium
hydrogen exchanger in maitotoxin-induced cell death in cultured rat cortical neurons. Toxicon 2009, 54,
95–102. [CrossRef] [PubMed]
47. Martin, V.; Vale, C.; Antelo, A.; Hirama, M.; Yamashita, S.; Vieytes, M.R.; Botana, L.M. Differential effects of
ciguatoxin and maitotoxin in primary cultures of cortical neurons. Chem. Res. Toxicol. 2014, 27, 1387–1400.
[CrossRef] [PubMed]
48. Sinkins, W.G.; Estacion, M.; Prasad, V.; Goel, M.; Shull, G.E.; Kunze, D.L.; Schilling, W.P. Maitotoxin converts
the plasmalemmal Ca2+ pump into a Ca2+-permeable nonselective cation channel. Am. J. Physiol. Cell Physiol.
2009, 297, C1533–C1543. [CrossRef] [PubMed]
49. De la Rosa, L.A.; Alvarez-Parrilla, E.; Martinez-Martinez, A. Biochemistry of maitotoxin. In Phycotoxins:
Chemistry and Biochemistry; Botana, L.M., Ed.; Blackwell Publishing Ltd.: Oxford, UK, 2007; pp. 55–74.
50. Lundy, P.M.; Nelson, P.; Mi, L.; Frew, R.; Minaker, S.; Vair, C.; Sawyer, T.W. Pharmacological differentiation
of the P2X(7) receptor and the maitotoxin-activated cationic channel. Eur. J. Pharmacol. 2004, 487, 17–28.
[CrossRef] [PubMed]
51. Konoki, K.; Hashimoto, M.; Murata, M.; Tachibana, K. Maitotoxin-induced calcium influx in erythrocyte
ghosts and rat glioma C6 cells, and blockade by gangliosides and other membrane lipids. Chem. Res. Toxicol.
1999, 12, 993–1001. [CrossRef] [PubMed]
52. Murata, M.; Gusovsky, F.; Sasaki, M.; Yokoyama, A.; Yasumoto, T.; Daly, J.W. Effect of maitotoxin analogs on
calcium influx and phosphoinositide breakdown in cultured cells. Toxicon 1991, 29, 1085–1096. [CrossRef]
53. Holmes, M.J.; Lewis, R.J. Purification and characterisation of large and small maitotoxins from cultured
Gambierdiscus toxicus. Nat. Toxins 1994, 2, 64–72. [CrossRef] [PubMed]
54. Murata, M.; Matsumori, N.; Konoki, K.; Oishi, T. Structural features of dinoflagellate toxins underlying
biological activity as viewed by NMR. Bull. Chem. Soc. Jpn. 2008, 81, 307–319. [CrossRef]
55. Holmes, M.J.; Lewis, R.J.; Gillespie, N.C. Toxicity of Australian and French Polynesian strains of Gambierdiscus
toxicus (Dinophyceae) grown in culture: Characterization of a new type of maitotoxin. Toxicon 1990, 28,
1159–1172. [CrossRef]
Mar. Drugs 2017, 15, 220 29 of 31
56. Lewis, R.J.; Holmes, M.J.; Alewood, P.F.; Jones, A. Ionspray mass spectrometry of ciguatoxin-1, maitotoxin-2
and -3, and related marine polyether toxins. Nat. Toxins 1994, 2, 56–63. [CrossRef] [PubMed]
57. Lewis, R.J.; Inserra, M.; Vetter, I.; Holland, W.C.; Hardison, D.R.; Tester, P.A.; Litaker, R.W. Rapid extraction
and identification of maitotoxin and ciguatoxin-like toxins from Caribbean and Pacific Gambierdiscus using a
new functional bioassay. PLoS ONE 2016, 11, e0160006. [CrossRef] [PubMed]
58. Litaker, R.W.; Vandersea, M.W.; Faust, M.A.; Kibler, S.R.; Chinain, M.; Holmes, M.J.; Holland, W.C.; Tester, P.A.
Taxonomy of Gambierdiscus including four new species, Gambierdiscus caribaeus, Gambierdiscus carolinianus,
Gambierdiscus carpenteri and Gambierdiscus ruetzleri (Gonyaulacales, Dinophyceae). Phycologia 2009, 48,
344–390. [CrossRef]
59. Smith, K.F.; Rhodes, L.; Verma, A.; Curley, B.G.; Harwood, D.T.; Kohli, G.S.; Solomona, D.; Rongo, T.;
Munday, R.; Murray, S.A. A new Gambierdiscus species (Dinophyceae) from Rarotonga, Cook Islands:
Gambierdiscus cheloniae sp. nov. Harmful Algae 2016, 60, 45–56. [CrossRef] [PubMed]
60. Fraga, S.; Rodríguez, F.; Riobó, P.; Bravo, I. Gambierdiscus balechii sp. nov. (Dinophyceae), a new benthic toxic
dinoflagellate from the Celebes Sea (SW Pacific Ocean). Harmful Algae 2016, 58, 93–105. [CrossRef] [PubMed]
61. Fraga, S.; Rodríguez, F.; Caillaud, A.; Diogène, J.; Raho, N.; Zapata, M. Gambierdiscus excentricus sp. nov.
(Dinophyceae), a benthic toxic dinoflagellate from the Canary Islands (NE Atlantic Ocean). Harmful Algae
2011, 11, 10–22. [CrossRef]
62. Fraga, S.; Rodríguez, F. Genus Gambierdiscus in the Canary Islands (NE Atlantic Ocean) with description
of Gambierdiscus silvae sp. nov., a new potentially toxic epiphytic benthic dinoflagellate. Protist 2014, 165,
839–853. [CrossRef] [PubMed]
63. Nishimura, T.; Sato, S.; Tawong, W.; Sakanari, H.; Yamaguchi, H.; Adachi, M. Morphology of Gambierdiscus
scabrosus sp. nov. (Gonyaulacales): A new epiphytic toxic dinoflagellate from coastal areas of Japan. J. Phycol.
2014, 50, 506–514. [CrossRef] [PubMed]
64. Kretzschmar, A.L.; Verma, A.; Harwood, D.T.; Hoppenrath, M.; Murray, S.A. Characterisation of
Gambierdiscus lapillus sp. nov. (Gonyaulacales, Dinophyceae): A new toxic dinoflagellate from the Great
Barrier Reef (Australia). J. Phycol. 2017, 53, 283–297. [CrossRef] [PubMed]
65. Gómez, F.; Qiu, D.J.; Lopes, R.M.; Lin, S.J. Fukuyoa paulensis gen. et sp. nov., a new genus for the globular
species of the dinoflagellate Gambierdiscus (Dinophyceae). PLoS ONE 2015, 10, e0119676. [CrossRef]
[PubMed]
66. Rhodes, L.; Smith, K.F.; Verma, A.; Curley, B.G.; Harwood, D.T.; Murray, S.; Kohli, G.S.; Solomona, D.;
Rongo, T.; Munday, R.; et al. A new species of Gambierdiscus (Dinophyceae) from the south-west Pacific:
Gambierdiscus honu sp. nov. Harmful Algae 2017, 65, 61–70. [CrossRef] [PubMed]
67. Tunin-Ley, A.; Chomérat, N.; Bilien, G.; Turquet, J. Taxonomic characterization of Gambierdiscus species
in Reunion Island, Indian Ocean. In Proceedings of the GdR Phycotox & GIS Cyano 2017, Gif-sur-Yvette,
France, 14–16 March 2017.
68. Holland, W.C.; Litaker, R.W.; Tomas, C.R.; Kibler, S.R.; Place, A.R.; Davenport, E.D.; Tester, P.A. Differences
in the toxicity of six Gambierdiscus (Dinophyceae) species measured using an in vitro human erythrocyte
lysis assay. Toxicon 2013, 65, 15–33. [CrossRef] [PubMed]
69. Pisapia, F.; Holland, W.C.; Hardison, D.R.; Litaker, R.W.; Fraga, S.; Nishimura, T.; Adachi, M.;
Nguyen-Ngoc, L.; Séchet, V.; Amzil, Z.; et al. Toxicity screening of 13 Gambierdiscus strains using neuro-2a
and erythrocyte lysis bioassays. Harmful Algae 2017, 63, 173–183. [CrossRef] [PubMed]
70. Chinain, M.; Darius, H.T.; Ung, A.; Cruchet, P.; Wang, Z.; Ponton, D.; Laurent, D.; Pauillac, S. Growth and
toxin production in the ciguatera-causing dinoflagellate Gambierdiscus polynesiensis (Dinophyceae) in culture.
Toxicon 2010, 56, 739–750. [CrossRef] [PubMed]
71. Rhodes, L.; Harwood, T.; Smith, K.; Argyle, P.; Munday, R. Production of ciguatoxin and maitotoxin by
strains of Gambierdiscus australes, G. pacificus and G. polynesiensis (Dinophyceae) isolated from Rarotonga,
Cook Islands (vol 39, pg 185, 2014). Harmful Algae 2016, 55, 295. [CrossRef] [PubMed]
72. Kohli, G.S. Diversity and Genetics of Australasian Dinoflagellates, Including Gambierdiscus spp. the Causative
Agent of Ciguatera Fish Poisoning; University of New South Wales: Sidney, Australia, 2013.
73. Rhodes, L.; Papiol, G.G.; Smith, K.; Harwood, T. Gambierdiscus cf. yasumotoi (Dinophyceae) isolated from
New Zealand’s sub-tropical northern coastal waters. N. Z. J. Mar. Freshw. Res. 2014, 48, 303–310.
Mar. Drugs 2017, 15, 220 30 of 31
74. Rhodes, L.L.; Smith, K.F.; Verma, A.; Murray, S.; Harwood, D.T.; Trnski, T. The dinoflagellate genera
Gambierdiscus and Ostreopsis from subtropical Raoul Island and North Meyer Island, Kermadec Islands. N. Z.
J. Mar. Freshw. Res. 2017, 1–15. [CrossRef]
75. Litaker, R.W.; Holland, W.C.; Hardison, D.R.; Pisapia, F.; Hess, P.; Tester, P. Ciguatoxicity of Gambierdiscus
and Fukuyoa species from the Caribbean and Gulf of Mexico. PLoS ONE 2017, unpublished.
76. Boada, L.D.; Zumbado, M.; Luzardo, O.P.; Almeida-González, M.; Plakas, S.M.; Granade, H.R.; Abraham, A.;
Jester, E.L.; Dickey, R.W. Ciguatera fish poisoning on the West Africa Coast: An emerging risk in the Canary
Islands (Spain). Toxicon 2010, 56, 1516–1519. [CrossRef] [PubMed]
77. Pérez-Arellano, J.L.; Luzardo, O.P.; Perez Brito, A.; Hernandez Cabrera, M.; Zumbado, M.; Carranza, C.;
Angel-Moreno, A.; Dickey, R.W.; Boada, L.D. Ciguatera fish poisoning, Canary Islands. Emerg. Infect. Dis.
2005, 11, 1981–1982. [CrossRef] [PubMed]
78. Nascimento, S.M.; Diniz, B.; de Alencar, A.G.; Menegueli, A.C.; Menezes, M. First record of the ciguatera
causing genus Gambierdiscus in Brazil. Harmful Algal News 2012, 45, 8–9.
79. Nascimento, S.M.; Melo, G.; Salgueiro, F.; Diniz, B.D.; Fraga, S. Morphology of Gambierdiscus excentricus
(Dinophyceae) with emphasis on sulcal plates. Phycologia 2015, 54, 628–639. [CrossRef]
80. Caillaud, A.; de la Iglesia, P.; Barber, E.; Eixarch, H.; Mohammad-Noor, N.; Yasumoto, T.; Diogène, J.
Monitoring of dissolved ciguatoxin and maitotoxin using solid-phase adsorption toxin tracking devices:
Application to Gambierdiscus pacificus in culture. Harmful Algae 2011, 10, 433–446. [CrossRef]
81. Kibler, S.R.; Litaker, R.W.; Holland, W.C.; Vandersea, M.W.; Tester, P.A. Growth of eight Gambierdiscus
(Dinophyceae) species: Effects of temperature, salinity and irradiance. Harmful Algae 2012, 19, 1–14.
[CrossRef]
82. Xu, Y.; Richlen, M.L.; Liefer, J.D.; Robertson, A.; Kulis, D.; Smith, T.B.; Parsons, M.L.; Anderson, D.M.
Influence of environmental variables on Gambierdiscus spp. (Dinophyceae) growth and distribution.
PLoS ONE 2016, 11, e0153197. [CrossRef] [PubMed]
83. Roeder, K.; Erler, K.; Kibler, S.; Tester, P.; Van The, H.; Nguyen-Ngoc, L.; Gerdts, G.; Luckas, B. Characteristic
profiles of ciguatera toxins in different strains of Gambierdiscus spp. Toxicon 2010, 56, 731–738. [CrossRef]
[PubMed]
84. Rodríguez, I.; Genta-Jouve, G.; Alfonso, C.; Calabro, K.; Alonso, E.; Sánchez, J.A.; Alfonso, A.; Thomas, O.P.;
Botana, L.M. Gambierone, a ladder-shaped polyether from the dinoflagellate Gambierdiscus belizeanus.
Org. Lett. 2015, 17, 2392–2395. [CrossRef] [PubMed]
85. Watanabe, R.; Uchida, H.; Suzuki, T.; Matsushima, R.; Nagae, M.; Toyohara, Y.; Satake, M.; Oshima, Y.;
Inoue, A.; Yasumoto, T. Gambieroxide, a novel epoxy polyether compound from the dinoflagellate
Gambierdiscus toxicus GTP2 strain. Tetrahedron 2013, 69, 10299–10303. [CrossRef]
86. Babinchak, J.A.; Jollow, D.J.; Voegtline, M.S.; Higerd, T.B. Toxin production by Gambierdiscus toxicus isolated
from the Florida Keys. Mar. Fish. Rev. 1986, 48, 53–56.
87. Nishimura, T.; Sato, S.; Tawong, W.; Sakanari, H.; Uehara, K.; Shah, M.M.; Suda, S.; Yasumoto, T.; Taira, Y.;
Yamaguchi, H.; et al. Genetic diversity and distribution of the ciguatera-causing dinoflagellate Gambierdiscus
spp. (Dinophyceae) in coastal areas of Japan. PLoS ONE 2013, 8, e60882. [CrossRef] [PubMed]
88. Bravo, I.; Figueroa, R.I.; Fraga, S. Cellular and nuclear morphological variability within a single species of
the toxigenic dinoflagellate genus Gambierdiscus: Relationship to life-cycle processes. Harmful Algae 2014, 40,
1–8. [CrossRef]
89. Litaker, R.W.; Vandersea, M.W.; Faust, M.A.; Kibler, S.R.; Nau, A.W.; Holland, W.C.; Chinain, M.;
Holmes, M.J.; Tester, P.A. Global distribution of ciguatera causing dinoflagellates in the genus Gambierdiscus.
Toxicon 2010, 56, 711–730. [CrossRef] [PubMed]
90. The, H.V.; Lam, N.N.; Larsen, J. On a toxic benthic dinoflagellate Gambierdiscus toxicus isolated from Cau
Island, South Central Viet Nam. In Proceedings of the 13th International Conference on Harmful Algae,
Hong Kong, China, 3–7 November 2008.
91. Satake, M.; Murata, M.; Yasumoto, T. The structure of CTX3C, a ciguatoxin congener isolated from cultured
Gambierdiscus toxicus. Tetrahedron Lett. 1993, 34, 1975–1978. [CrossRef]
92. Caillaud, A.; Yasumoto, T.; Diogène, J. Detection and quantification of maitotoxin-like compounds using a
neuroblastoma (Neuro-2a) cell based assay. Application to the screening of maitotoxin-like compounds in
Gambierdiscus spp. Toxicon 2010, 56, 36–44. [CrossRef] [PubMed]
Mar. Drugs 2017, 15, 220 31 of 31
93. Hardison, D.R.; Holland, W.C.; McCall, J.R.; Bourdelais, A.J.; Baden, D.G.; Darius, H.T.; Chinain, M.;
Tester, P.A.; Shea, D.; Quintana, H.A.; et al. Fluorescent receptor binding assay for detecting ciguatoxins in
fish. PLoS ONE 2016, 11, e0153348. [CrossRef] [PubMed]
94. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and
cytotoxicity assays. J. Immunol. Methods 1983, 65, 55–63. [CrossRef]
95. O’Brien, P.J.; Irwin, W.; Diaz, D.; Howard-Cofield, E.; Krejsa, C.M.; Slaughter, M.R.; Gao, B.; Kaludercic, N.;
Angeline, A.; Bernardi, P.; et al. High concordance of drug-induced human hepatotoxicity with in vitro
cytotoxicity measured in a novel cell-based model using high content screening. Arch. Toxicol. 2006, 80,
580–604. [CrossRef] [PubMed]
96. Singh, S.; Carpenter, A.E.; Genovesio, A. Increasing the content of High-Content Screening. J. Biomol. Screen.
2014, 19, 640–650. [CrossRef] [PubMed]
97. Sérandour, A.L.; Ledreux, A.; Morin, B.; Derick, S.; Augier, E.; Lanceleur, R.; Hamlaoui, S.; Moukha, S.;
Furger, C.; Biré, R.; et al. Collaborative study for the detection of toxic compounds in shellfish extracts
using cell-based assays. Part I: Screening strategy and pre-validation study with lipophilic marine toxins.
Anal. Bioanal. Chem. 2012, 403, 1983–1993. [CrossRef] [PubMed]
98. Vial, J.; Jardy, A. Experimental comparison of the different approaches to estimate LOD and LOQ of an
HPLC method. Anal. Chem. 1999, 71, 2672–2677. [CrossRef]
99. Sanagi, M.M.; Ling, S.L.; Nasir, Z.; Hermawan, D.; Ibrahim, W.A.; Abu Naim, A. Comparison of
signal-to-noise, blank determination, and linear regression methods for the estimation of detection and
quantification limits for volatile organic compounds by gas chromatography. J. AOAC Int. 2009, 92, 1833–1838.
[PubMed]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
